(Exact Name of Registrant as Specified in Its Charter) |
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: | ||||
Title of Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |||
Emerging growth company | |||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Date: | February 28, 2020 | COLONY CAPITAL, INC. | |
By: | /s/ Mark M. Hedstrom | ||
Mark M. Hedstrom | |||
Chief Financial Officer, Chief Operating Officer and Treasurer |
• | Highly profitable sale of our industrial real estate portfolio for $5.7 billion |
• | Closing of our inaugural $4.1 billion digital infrastructure fund, which substantially surpassed its initial fundraising target |
• | Combination with Digital Bridge, the leading global investment management firm focused on digital infrastructure |
• | $185 million controlling investment in DataBank, an owner of edge data centers serving fast growing markets |
• | Net loss attributable to common stockholders was $(26.3) million, or $(0.06) per share, for the fourth quarter and $(1.15) billion, or $(2.41) per share, for the full year |
• | As part of the Company’s ongoing transition and rotation to an investment management and operating business focused on digital real estate and infrastructure, the Company continues to pivot away from certain of its non-digital investment management businesses and, as such, the Company recorded impairments to the intangible carrying value of certain of its non-digital investment management businesses in the amount of $411 million in the fourth quarter of 2019 |
• | Core FFO was $47.6 million, or $0.09 per share, for the fourth quarter and $266.3 million, or $0.50 per share, for the full year |
• | For fourth quarter 2019, excluding net losses of $21.4 million primarily related to net investment losses in Other Equity and Debt, Core FFO was $69.0 million, or $0.13 per share; for full year 2019, excluding net investment losses of $52.0 million, Core FFO was $318.3 million, or $0.60 per share |
• | The Company’s Board of Directors declared and paid a fourth quarter 2019 dividend of $0.11 per share to holders of Class A and B common stock |
• | Acquired a 20.4% controlling interest in DataBank, a leading private owner and manager of edge data centers in the U.S., for approximately $185 million, representing the Company’s inaugural direct balance sheet investment in digital real estate |
• | Increased digital assets under management (“AUM”) to $13.8 billion as of December 31, 2019, which represents approximately 29% of the Company’s overall AUM and is a significant transformation from $1.9 billion of Digital AUM as of December 31, 2018 |
• | Completed the acquisitions of Beanfield Technologies Inc., a Canadian fiber network owner and operator, and Highline do Brasil, a telecommunications infrastructure provider in Brazil, by Digital Colony Partners (“DCP”), the Company’s $4.1 billion digital real estate and infrastructure private equity fund |
• | Completed the sale of the Company’s light industrial portfolio, including the related operating platform, for $5.7 billion, which resulted in a net cash gain and incentive fees of approximately $475 million and net cash proceeds of approximately $1.25 billion for the Company’s share |
• | Completed the planned sales and/or monetization of $66 million of assets, with net equity proceeds of $35 million within the Other Equity and Debt segment, and for full year 2019, sold $717 million of assets with net equity proceeds of $566 million |
• | Completed the sale of three unencumbered hospitals resulting in net proceeds to the Company of $82 million; in June 2019 the Company had initially contributed $175 million to refinance its share of $1.725 billion of healthcare debt and removed these assets from the collateral pool at that time, such that these sale proceeds effectively decrease the equity contribution required to complete the refinancing to a net amount of $93 million |
• | Announced and completed the redemption of all its outstanding 8.25% Series B and 8.75% Series E cumulative redeemable perpetual preferred stock for $408 million, including accrued dividends of $5 million, which was settled in January 2020 eliminating $34 million of annualized preferred dividends |
• | Refinanced a £212 million loan on a U.K. portfolio of senior housing assets and a $48 million loan on skilled nursing facilities portfolios, which, together with previously completed refinancing transactions in 2019, addresses all material near-term healthcare real estate loan maturities |
• | Refinanced an aggregate $982 million of debt on two hospitality portfolios significantly extending the outside maturity dates to 2026 at slightly lower interest rates on average |
• | Raised additional third-party capital of €115 million for AccorInvest bringing total third-party capital raised to €717 million alongside the Company’s investment of €46 million |
• | Successfully closed a $125 million senior financing and $60 million co-invest equity syndication of Alpine Energy Capital, LLC's (“Alpine”) $320 million commitment to an energy development joint venture with California Resources Corporation (NYSE: CRC) |
• | DCP invested and committed to three digital real estate and infrastructure investments and is now 73% committed (pro forma for the completion of the Zayo acquisition) |
• | Completed the sale of the Company’s 27.2% ownership interest in RXR Realty, a non-wholly owned real estate investment management platform, for approximately $200 million resulting in a realized pre-tax gain of $106 million |
• | Announced that the Company is pursuing a disposition of its management contract with Colony Credit Real Estate, Inc. (NYSE: CLNC), which may include a potential internalization of the Company’s management contract with CLNC, a sale of the CLNC management contract to a third party or another transaction that would result in the disposal of the CLNC management contract |
• | Achieved well over 100% of the expected total $50 to $55 million, or $45 to $50 million on a cash basis, of the previously announced annual compensation and administrative cost savings in the fourth quarter of 2018 on a run rate basis |
• | In connection with CLNC’s recent announcement that Kevin Traenkle has resigned as CLNC’s Chief Executive Officer and President, the Company announced that Mr. Traenkle will be stepping down as the Colony Capital’s Chief Investment Officer, effective February 29, 2020 |
• | Announced that Justin Metz has stepped down as a member of the Company’s Board of Directors (including its committees, as applicable), effective February 25, 2020. Separately, in furtherance of the previously announced process undertaken by the Nominating and Corporate Governance Committee (“NCG Committee”) of the Company’s Board, the Company also announced that it has engaged an executive search firm to assist the Company’s Board, including the NCG Committee, in its ongoing process to evaluate board composition, governance and refreshment matters, with a focus on identifying potential director candidates with appropriate digital experience to join the Company’s Board as the Company continues to execute on its digital evolution |
• | As of February 25, 2020, the Company had significant liquidity of $1.3 billion including $520 million cash-on-hand and through availability under its revolving credit facility |
i. | accelerate the expansion into digital real estate with the acquisition of a 20% interest in DataBank for approximately $185 million; |
ii. | fund the remaining approximately $200 million commitment to DCP; and |
iii. | redeem $403 million of high cost preferred equity to improve the Company’s capital structure. |
• | With respect to the healthcare and hospitality units, the Company successfully addressed all material near-term debt maturities allowing the respective business unit leaders to focus on improving cash flows through operational management and capital expenditures. |
• | With respect to Other Equity and Debt (“OED”), the Company has a 2020 asset sale and monetization target of $300 to $500 million with the goal to ultimately monetize the entire OED portfolio, except for Digital related investments, such as the Company’s investment in DataBank and GP co-investment in DCP. |
• | With respect to the Company’s 48 million shares in CLNC, the Company will evaluate sales in a responsible manner, but believes the current CLNC share price represents an excessive discount to book value. |
• | In addition, the Company is pursuing a disposition of its management contract with CLNC, but there can be no assurance that the Company will consummate any transaction. |
• | Further, with respect to other non-digital investment management businesses, the Company is exploring all potential opportunities to maximize value of the credit and opportunity fund investment management business, while minimizing balance sheet commitments, including, but not limited to, joint ventures with third party capital providers, sales and/or realignment of operational management. |
($ in thousands, except per share data) | Fourth quarter 2019 | Full Year 2019 | |||||
Net loss attributable to common stockholders | $ | (26,251 | ) | $ | (1,152,207 | ) | |
Net loss attributable to common stockholders per share | (0.06 | ) | (2.41 | ) | |||
Core FFO | 47,590 | 266,278 | |||||
Core FFO per share | 0.09 | 0.50 | |||||
Core FFO excluding net investment losses | 68,972 | 318,257 | |||||
Core FFO excluding net investment losses per share | 0.13 | 0.60 |
($ in millions) | Consolidated | CLNY OP Share | |||||
Goodwill and $10 million related to Investment Management Intangibles | $ | 411.0 | $ | 411.0 | |||
Healthcare | 43.1 | 33.3 | |||||
Hospitality | 14.6 | 13.4 | |||||
Other Equity and Debt | 2.5 | (1.1 | ) | ||||
Sub-total impairments | 471.2 | 456.6 | |||||
CRE Securities other-than-temporary-impairments (OTTI) and unconsolidated investments Equity Method impairments in Other Equity and Debt | 13.2 | 13.2 | |||||
Grand total impairments | $ | 484.4 | $ | 469.8 |
December 31, 2019 | September 30, 2019 | ||||||||||||
($ in billions) | Amount | % of Grand Total | Amount | % of Grand Total | |||||||||
Balance Sheet (CLNY OP Share): | |||||||||||||
Healthcare | $ | 3.6 | 7.3 | % | $ | 3.7 | 6.9 | % | |||||
Industrial | 0.2 | 0.4 | % | 1.7 | 3.2 | % | |||||||
Hospitality | 3.8 | 7.8 | % | 3.8 | 7.1 | % | |||||||
Other Equity and Debt(1) | 3.1 | 6.3 | % | 2.8 | 5.3 | % | |||||||
CLNC(2) | 2.0 | 4.1 | % | 2.0 | 3.8 | % | |||||||
Balance Sheet Subtotal | 12.7 | 25.9 | % | 14.0 | 26.3 | % | |||||||
Investment Management: | |||||||||||||
Digital(3) | 13.5 | 27.7 | % | 13.8 | 25.9 | % | |||||||
Other Institutional Funds | 8.5 | 17.3 | % | 10.6 | 19.9 | % | |||||||
Colony Credit Real Estate (NYSE:CLNC)(4) | 3.5 | 7.1 | % | 3.5 | 6.6 | % | |||||||
Retail Companies | 3.4 | 6.9 | % | 3.4 | 6.4 | % | |||||||
Non-Wholly Owned REIM Platforms(5) | 7.4 | 15.1 | % | 8.0 | 14.9 | % | |||||||
Investment Management Subtotal | 36.3 | 74.1 | % | 39.3 | 73.7 | % | |||||||
Grand Total | $ | 49.0 | 100.0 | % | $ | 53.3 | 100.0 | % |
(1) | Includes approximately $0.3 billion and $0.05 billion, as of December 31, 2019 and September 30, 2019, respectively of digital investments. |
(2) | Represents the Company’s 36% ownership share of CLNC’s total pro-rata share of assets of $5.6 billion as of December 31, 2019 and September 30, 2019. |
(3) | Approximately $0.2 billion transferred to Other Equity and Debt as a result of acquisition of a 20.4% interest in DataBank from existing third-party investors. |
(4) | Represents third-party 64% ownership share of CLNC’s total pro-rata share of assets of $5.6 billion as of December 31, 2019 and September 30, 2019. |
(5) | REIM: Real Estate Investment Management (RXR Realty LLC, Alpine Energy LLC and American Healthcare Investors) |
Consolidated | CLNY OP | Same Store | ||||||||||||||||||||
NOI | Share NOI(1) | Consolidated NOI | Occupancy %(2) | TTM Lease Coverage(3) | ||||||||||||||||||
($ in millions) | Q4 2019 | Q4 2019 | Q4 2019 | Q3 2019 | Q4 2019 | Q3 2019 | 9/30/19 | 6/30/19 | ||||||||||||||
Senior Housing - Operating | $ | 15.7 | $ | 11.1 | $ | 15.7 | $ | 15.6 | 86.5 | % | 86.2 | % | N/A | N/A | ||||||||
Medical Office Buildings (MOB) | 13.8 | 9.8 | 13.8 | 12.9 | 82.2 | % | 82.2 | % | N/A | N/A | ||||||||||||
Triple-Net Lease: | ||||||||||||||||||||||
Senior Housing | 16.1 | 11.4 | 15.8 | 13.8 | 79.7 | % | 79.8 | % | 1.3x | 1.3x | ||||||||||||
Skilled Nursing Facilities | 24.4 | 17.3 | 24.4 | 23.4 | 82.7 | % | 82.5 | % | 1.2x | 1.2x | ||||||||||||
Hospitals | 6.6 | 4.7 | 4.3 | 0.8 | 65.3 | % | 61.3 | % | 1.3x | 1.3x | ||||||||||||
Healthcare Total | $ | 76.6 | $ | 54.3 | $ | 74.0 | $ | 66.5 |
(1) | CLNY OP Share NOI represents fourth quarter 2019 Consolidated NOI multiplied by CLNY OP’s ownership interest as of December 31, 2019. |
(2) | Occupancy % for Senior Housing - Operating represents average during the presented quarter, for MOB’s represents as of last day in the quarter and for other types represents average during the prior quarter. |
(3) | Represents the ratio of the tenant’s/operator’s EBITDAR to cash rent payable to the Company’s Healthcare Real Estate segment on a trailing twelve month basis. |
Same Store | |||||||||||||||||||||||||||||||||
Consolidated | CLNY OP Share | Consolidated | Avg. Daily Rate | RevPAR(3) | |||||||||||||||||||||||||||||
NOI before FF&E Reserve(1) | NOI before FF&E Reserve(2) | NOI before FF&E Reserve | Occupancy %(4) | (In dollars)(4) | (In dollars)(4) | ||||||||||||||||||||||||||||
($ in millions) | Q4 2019 | Q4 2019 | Q4 2019 | Q4 2018 | Q4 2019 | Q4 2018 | Q4 2019 | Q4 2018 | Q4 2019 | Q4 2018 | |||||||||||||||||||||||
Marriott | $ | 41.2 | $ | 38.7 | $ | 41.2 | $ | 47.4 | 69.4 | % | 70.6 | % | $ | 124 | $ | 127 | $ | 86 | $ | 89 | |||||||||||||
Hilton | 9.9 | 9.3 | 9.6 | 9.5 | 75.1 | % | 75.8 | % | 125 | 127 | 94 | 96 | |||||||||||||||||||||
Other | 3.0 | 2.8 | 3.0 | 3.1 | 77.5 | % | 77.9 | % | 128 | 134 | 100 | 105 | |||||||||||||||||||||
Total/W.A. | $ | 54.1 | $ | 50.8 | $ | 53.8 | $ | 60.0 | 70.8 | % | 71.9 | % | $ | 125 | $ | 127 | $ | 88 | $ | 91 |
(1) | Fourth quarter 2019 consolidated FF&E reserve was $8.1 million. |
(2) | CLNY OP Share NOI before FF&E Reserve represents fourth quarter 2019 Consolidated NOI before FF&E Reserve multiplied by CLNY OP’s ownership interest as of December 31, 2019. |
(3) | RevPAR, or revenue per available room, represents a hotel's total guestroom revenue divided by the room count and the number of days in the period being measured. |
(4) | For each metric, data represents average during the presented quarter. |
CLNY OP Share | |||||||||||||||
Undepreciated Carrying Value | |||||||||||||||
December 31, 2019 | September 30, 2019 | ||||||||||||||
($ in millions) | Assets | Equity | Assets | Equity | |||||||||||
Strategic: | |||||||||||||||
Digital - direct investments and GP co-investments | $ | 343 | $ | 233 | $ | 53 | $ | 53 | |||||||
Other GP co-investments | 1,110 | 637 | 1,092 | 610 | |||||||||||
Strategic Subtotal | 1,453 | 870 | 1,145 | 663 | |||||||||||
Strategic % of Total Other Equity and Debt | 47 | % | 48 | % | 41 | % | 41 | % | |||||||
Non-Strategic: | |||||||||||||||
Other Real Estate Equity & Albertsons | 1,165 | 551 | 1,185 | 546 | |||||||||||
Real Estate Debt | 247 | 247 | 244 | 244 | |||||||||||
Net Lease Real Estate Equity | 187 | 83 | 184 | 80 | |||||||||||
CRE Securities and Real Estate Private Equity Funds | 60 | 60 | 65 | 65 | |||||||||||
Non-Strategic Subtotal | 1,659 | 941 | 1,678 | 935 | |||||||||||
Non-Strategic % of Total Other Equity and Debt | 53 | % | 52 | % | 59 | % | 59 | % | |||||||
Total Other Equity and Debt | $ | 3,112 | $ | 1,811 | $ | 2,823 | $ | 1,598 |
December 31, 2019 | December 31, 2018 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 1,205,190 | $ | 461,912 | ||||
Restricted cash | 203,923 | 364,605 | ||||||
Real estate, net | 10,860,518 | 10,826,010 | ||||||
Loans receivable, net | 1,552,824 | 1,659,217 | ||||||
Equity and debt investments | 2,313,805 | 2,529,747 | ||||||
Goodwill | 1,452,891 | 1,514,561 | ||||||
Deferred leasing costs and intangible assets, net | 638,853 | 445,930 | ||||||
Assets held for sale | 870,052 | 3,969,635 | ||||||
Other assets | 682,648 | 400,143 | ||||||
Due from affiliates | 51,480 | 43,489 | ||||||
Total assets | $ | 19,832,184 | $ | 22,215,249 | ||||
Liabilities | ||||||||
Debt, net | $ | 8,983,908 | $ | 8,975,372 | ||||
Accrued and other liabilities | 1,015,898 | 634,144 | ||||||
Intangible liabilities, net | 111,484 | 147,470 | ||||||
Liabilities related to assets held for sale | 268,152 | 1,218,495 | ||||||
Due to affiliates | 34,064 | — | ||||||
Dividends and distributions payable | 83,301 | 84,013 | ||||||
Preferred stock redemptions payable | 402,855 | — | ||||||
Total liabilities | 10,899,662 | 11,059,494 | ||||||
Commitments and contingencies | ||||||||
Redeemable noncontrolling interests | 6,107 | 9,385 | ||||||
Equity | ||||||||
Stockholders’ equity: | ||||||||
Preferred stock, $0.01 par value per share; $1,033,750 and $1,436,605 liquidation preference, respectively; 250,000 shares authorized; 41,350 and 57,464 shares issued and outstanding, respectively | 999,490 | 1,407,495 | ||||||
Common stock, $0.01 par value per share | ||||||||
Class A, 949,000 shares authorized; 487,044 and 483,347 shares issued and outstanding, respectively | 4,871 | 4,834 | ||||||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | 7 | 7 | ||||||
Additional paid-in capital | 7,553,599 | 7,598,019 | ||||||
Accumulated deficit | (3,389,592 | ) | (2,018,302 | ) | ||||
Accumulated other comprehensive income | 47,668 | 13,999 | ||||||
Total stockholders’ equity | 5,216,043 | 7,006,052 | ||||||
Noncontrolling interests in investment entities | 3,254,188 | 3,779,728 | ||||||
Noncontrolling interests in Operating Company | 456,184 | 360,590 | ||||||
Total equity | 8,926,415 | 11,146,370 | ||||||
Total liabilities, redeemable noncontrolling interests and equity | $ | 19,832,184 | $ | 22,215,249 |
Three Months Ended December 31, | Year Ended December 31, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Revenues | ||||||||||||||||
Property operating income | $ | 446,568 | $ | 459,568 | $ | 1,856,409 | $ | 1,960,559 | ||||||||
Interest income | 45,409 | 47,262 | 166,771 | 214,588 | ||||||||||||
Fee income | 45,600 | 37,710 | 223,915 | 144,443 | ||||||||||||
Other income | 14,784 | 11,590 | 79,259 | 47,352 | ||||||||||||
Total revenues | 552,361 | 556,130 | 2,326,354 | 2,366,942 | ||||||||||||
Expenses | ||||||||||||||||
Property operating expense | 266,576 | 279,120 | 1,090,909 | 1,150,656 | ||||||||||||
Interest expense | 128,877 | 137,441 | 535,538 | 552,838 | ||||||||||||
Investment and servicing expense | 26,696 | 11,567 | 78,258 | 67,113 | ||||||||||||
Transaction costs | 685 | 3,681 | 3,607 | 7,266 | ||||||||||||
Placement fees | 1,429 | 1,138 | 1,802 | 7,615 | ||||||||||||
Depreciation and amortization | 110,053 | 111,321 | 489,792 | 443,302 | ||||||||||||
Provision for loan loss | 33 | 15,901 | 35,880 | 43,034 | ||||||||||||
Impairment loss | 471,227 | 288,494 | 1,146,443 | 587,275 | ||||||||||||
Compensation expense | ||||||||||||||||
Cash and equity-based compensation | 53,836 | 69,797 | 214,826 | 213,882 | ||||||||||||
Carried interest and incentive fee compensation | 3,300 | 5,950 | 16,564 | 7,485 | ||||||||||||
Administrative expenses | 25,812 | 23,041 | 90,356 | 92,431 | ||||||||||||
Total expenses | 1,088,524 | 947,451 | 3,703,975 | 3,172,897 | ||||||||||||
Other income (loss) | ||||||||||||||||
Gain on sale of real estate assets | 19,162 | 67,729 | 62,916 | 159,598 | ||||||||||||
Other gain (loss), net | (10,165 | ) | (82,025 | ) | (193,302 | ) | 51,706 | |||||||||
Equity method earnings (losses) | 38,064 | (43,939 | ) | (140,384 | ) | (9,601 | ) | |||||||||
Equity method earnings—carried interest | 5,424 | 5,688 | 11,682 | 9,525 | ||||||||||||
Loss before income taxes | (483,678 | ) | (443,868 | ) | (1,636,709 | ) | (594,727 | ) | ||||||||
Income tax benefit (expense) | (252 | ) | 24,691 | (14,003 | ) | 59,970 | ||||||||||
Loss from continuing operations | (483,930 | ) | (419,177 | ) | (1,650,712 | ) | (534,757 | ) | ||||||||
Income from discontinued operations | 1,415,658 | 11,482 | 1,501,797 | 39,582 | ||||||||||||
Net loss | 931,728 | (407,695 | ) | (148,915 | ) | (495,175 | ) | |||||||||
Net income (loss) attributable to noncontrolling interests: | ||||||||||||||||
Redeemable noncontrolling interests | 242 | (5,750 | ) | 2,559 | (3,708 | ) | ||||||||||
Investment entities | 938,616 | (6,523 | ) | 990,360 | 67,994 | |||||||||||
Operating Company | (2,867 | ) | (25,345 | ) | (93,027 | ) | (39,854 | ) | ||||||||
Net loss attributable to Colony Capital, Inc. | (4,263 | ) | (370,077 | ) | (1,048,807 | ) | (519,607 | ) | ||||||||
Preferred stock redemption | (5,150 | ) | — | (5,150 | ) | (3,995 | ) | |||||||||
Preferred stock dividends | 27,138 | 27,137 | 108,550 | 117,097 | ||||||||||||
Net loss attributable to common stockholders | $ | (26,251 | ) | $ | (397,214 | ) | $ | (1,152,207 | ) | $ | (632,709 | ) | ||||
Basic loss per share | ||||||||||||||||
Loss from continuing operations per basic common share | $ | (0.95 | ) | $ | (0.83 | ) | $ | (3.38 | ) | $ | (1.31 | ) | ||||
Net loss per basic common share | $ | (0.06 | ) | $ | (0.82 | ) | $ | (2.41 | ) | $ | (1.28 | ) | ||||
Diluted loss per share | ||||||||||||||||
Loss from continuing operations per diluted common share | $ | (0.95 | ) | $ | (0.83 | ) | $ | (3.38 | ) | $ | (1.31 | ) | ||||
Net loss per diluted common share | $ | (0.06 | ) | $ | (0.82 | ) | $ | (2.41 | ) | $ | (1.28 | ) | ||||
Weighted average number of shares | ||||||||||||||||
Basic | 479,776 | 484,754 | 479,588 | 496,993 | ||||||||||||
Diluted | 479,776 | 484,754 | 479,588 | 496,993 |
Three Months Ended December 31, 2019 | Year Ended December 31, 2019 | |||||||
Net loss attributable to common stockholders | $ | (26,251 | ) | $ | (1,152,207 | ) | ||
Adjustments for FFO attributable to common interests in Operating Company and common stockholders: | ||||||||
Net loss attributable to noncontrolling common interests in Operating Company | (2,867 | ) | (93,027 | ) | ||||
Real estate depreciation and amortization | 118,253 | 548,766 | ||||||
Impairment of real estate | 60,273 | 351,395 | ||||||
Gain from sales of real estate | (1,449,040 | ) | (1,524,290 | ) | ||||
Less: Adjustments attributable to noncontrolling interests in investment entities | 910,702 | 719,225 | ||||||
FFO attributable to common interests in Operating Company and common stockholders | (388,930 | ) | (1,150,138 | ) | ||||
Additional adjustments for Core FFO attributable to common interests in Operating Company and common stockholders: | ||||||||
Gains and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO (1) | 637 | (47,172 | ) | |||||
Gains and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment | 399,999 | 809,419 | ||||||
CLNC Core Earnings & NRE Cash Available for Distribution adjustments (2) | (5,401 | ) | 263,707 | |||||
Equity-based compensation expense | 20,154 | 48,482 | ||||||
Straight-line rent revenue and expense | (5,735 | ) | (18,462 | ) | ||||
Amortization of acquired above- and below-market lease values, net | (9,991 | ) | (20,884 | ) | ||||
Amortization of deferred financing costs and debt premiums and discounts | 49,253 | 108,409 | ||||||
Unrealized fair value losses on interest rate and foreign currency hedges, and foreign currency remeasurements and realized gains and losses on interest rate hedging instruments existing at the time of the January 2017 merger with remaining terms greater than one year that served as economic hedges for any financing or refinancing of the Company's real estate verticals | (889 | ) | 239,709 | |||||
Acquisition and merger-related transaction costs | (944 | ) | 3,335 | |||||
Restructuring and merger integration costs (3) | 16,684 | 36,406 | ||||||
Amortization and impairment of investment management intangibles | 8,640 | 89,371 | ||||||
Non-real estate depreciation and amortization | 1,922 | 6,652 | ||||||
Gain on consolidation of equity method investment | — | (51,400 | ) | |||||
Amortization of gain on remeasurement of consolidated investment entities | 6 | 3,813 | ||||||
Tax effect of Core FFO adjustments, net | (7,864 | ) | (18,231 | ) | ||||
Preferred share redemption gain | (5,150 | ) | (5,150 | ) | ||||
Less: Adjustments attributable to noncontrolling interests in investment entities | (24,801 | ) | (31,588 | ) | ||||
Core FFO attributable to common interests in Operating Company and common stockholders | $ | 47,590 | $ | 266,278 | ||||
FFO per common share / common OP unit (4) | $ | (0.72 | ) | $ | (2.18 | ) | ||
FFO per common share / common OP unit—diluted (4)(5) | $ | (0.72 | ) | $ | (2.18 | ) | ||
Core FFO per common share / common OP unit (4) | $ | 0.09 | $ | 0.50 | ||||
Core FFO per common share / common OP unit—diluted (4)(5)(6) | $ | 0.09 | $ | 0.50 | ||||
Weighted average number of common OP units outstanding used for FFO and Core FFO per common share and OP unit (4) | 541,263 | 527,691 | ||||||
Weighted average number of common OP units outstanding used for FFO per common share and OP unit—diluted (4)(5) | 541,263 | 527,691 | ||||||
Weighted average number of common OP units outstanding used for Core FFO per common share and OP unit—diluted (4)(5)(6) | 541,263 | 528,756 |
(1) | For the three months ended December 31, 2019, net of $18.0 million consolidated or $9.6 million CLNY OP share and for the nine months ended December 31, 2019, net of $111.9 million consolidated or $70.7 million CLNY OP share of depreciation, amortization and impairment charges previously adjusted to calculate FFO. |
(2) | Represents adjustments to align the Company’s Core FFO with CLNC’s definition of Core Earnings and NRE’s definition of Cash Available for Distribution (“CAD”) to reflect the Company’s percentage interest in the respective company’s earnings. |
(3) | Restructuring and merger integration costs primarily represent costs and charges incurred as a result of the corporate restructuring and reorganization plan announced in November 2018 and the implementation of the digital evolution, including the completed sale of the Industrial business, NorthStar Realty Europe and future sales and disposition of non-digital businesses, platforms and investments. These costs and charges include severance, retention, relocation, transition and other related restructuring costs, which are not reflective of the Company’s core operating performance and the Company does not expect to incur these costs subsequent to the completion of the corporate restructuring and reorganization plan and the digital evolution. |
(4) | Calculated based on weighted average shares outstanding including participating securities and assuming the exchange of all common OP units outstanding for common shares. |
(5) | For the three and twelve months ended December 31, 2019, excluded from the calculation of diluted FFO and Core FFO per share is the effect of adding back interest expense associated with convertible senior notes and weighted average dilutive common share equivalents for the assumed conversion of the convertible senior notes as the effect of including such interest expense and common share equivalents would be antidilutive. |
(6) | For the three months ended December 31, 2019, there were no performance stock units, which were subject to both a service condition and market condition, and shares of non-participating restricted stock included in the calculation of diluted Core FFO per share. For the twelve months ended December 31, 2019, included in the calculation of diluted Core FFO per share are 990,700 weighted average performance stock units, which are subject to both a service condition and market condition, and 74,100 weighted average shares of non-participating restricted stock. |
Three Months Ended December 31, 2019 | ||||||||||||
(In thousands) | Healthcare | Industrial(1) | Hospitality | |||||||||
Total revenues | $ | 154,378 | $ | 77,611 | $ | 186,450 | ||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (11,370 | ) | (3,196 | ) | 313 | |||||||
Interest income | (31 | ) | (486 | ) | 6 | |||||||
Other income | (300 | ) | — | 70 | ||||||||
Property operating expenses (2) | (66,106 | ) | (19,382 | ) | (132,710 | ) | ||||||
Compensation and administrative expense (2) | — | (1,386 | ) | — | ||||||||
NOI(3) | $ | 76,571 | $ | 53,161 | $ | 54,129 |
(1) | Industrial financial results are classified as discontinued operations on the Company's consolidated statement of operations for the three months ended December 31, 2019. |
(2) | For healthcare and hospitality, property operating expenses include property management fees paid to third parties. For industrial, there are direct costs of managing the portfolio which are included in compensation expense. |
(3) | For hospitality, NOI is before FF&E Reserve. |
Three Months Ended December 31, 2019 | ||||||||||||
(In thousands) | Healthcare | Industrial(1) | Hospitality | |||||||||
Net income (loss) | $ | (38,608 | ) | $ | 1,426,219 | $ | (43,119 | ) | ||||
Adjustments: | ||||||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (11,370 | ) | (3,196 | ) | 313 | |||||||
Interest income | (31 | ) | (486 | ) | 6 | |||||||
Interest expense | 41,930 | 36,381 | 45,484 | |||||||||
Transaction, investment and servicing costs | 3,137 | 66 | 1,787 | |||||||||
Depreciation and amortization | 41,208 | 9,323 | 36,035 | |||||||||
Impairment loss | 43,132 | — | 14,649 | |||||||||
Compensation and administrative expense | 2,482 | 20,265 | 2,096 | |||||||||
Gain on sale of real estate | (551 | ) | (1,429,822 | ) | — | |||||||
Other (gain) loss, net | (5,690 | ) | (1,407 | ) | (1,492 | ) | ||||||
Other income | (300 | ) | — | 70 | ||||||||
Income tax (benefit) expense | 1,232 | (4,182 | ) | (1,700 | ) | |||||||
NOI(2) | $ | 76,571 | $ | 53,161 | $ | 54,129 |
(1) | Industrial financial results are classified as discontinued operations on the Company's consolidated statement of operations for the three months ended December 31, 2019. |
(2) | For hospitality, NOI is before FF&E Reserve. |
(In thousands) | Net Income (Loss) | ||||
Healthcare | $ | (38,608 | ) | ||
Industrial | 1,426,219 | ||||
Hospitality | (43,119 | ) | |||
CLNC | 13,064 | ||||
Other Equity and Debt | 27,185 | ||||
Investment Management | (400,486 | ) | |||
Amounts Not Allocated to Segments | (52,527 | ) | |||
Total Consolidated | $ | 931,728 |
Cautionary Statement Regarding Forward-Looking Statements |
Colony Capital | Supplemental Financial Report |
Important Note Regarding Non-GAAP Financial Measures |
Colony Capital | Supplemental Financial Report |
Important Note Regarding Non-GAAP Financial Measures |
Colony Capital | Supplemental Financial Report |
Note Regarding CLNY Reportable Segments / Consolidated and OP Share of Consolidated Amounts |
Colony Capital | Supplemental Financial Report |
Table of Contents |
Page | |||
I. | 6-13 | ||
II. | Financial Overview | ||
a. | 14 | ||
b. | 15-16 | ||
III. | Financial Results | ||
a. | 17 | ||
b. | 18 | ||
c. | 19 | ||
d. | 20 | ||
e. | 21 | ||
IV. | Capitalization | ||
a. | 22 | ||
b. | 23 | ||
c. | 24 | ||
d. | 25 | ||
e. | 26 | ||
V. | Investment Management | ||
a. | Summary Metrics | 27-28 | |
b. | Assets Under Management | 29 | |
VI. | Healthcare Real Estate | ||
a. | Summary Metrics and Operating Results | 30 | |
b. | Portfolio Overview | 31-32 | |
Page | |||
VII. | Hospitality Real Estate | ||
a. | 33 | ||
b. | 34 | ||
VIII. | CLNC | ||
a. | 35 | ||
IX. | 36 | ||
a. | 37 | ||
b. | 38 | ||
c. | 39-41 | ||
d. | 42 | ||
X. | Appendices | ||
a. | 44-45 | ||
b. | 46-47 | ||
c. | Industrial Real Estate - Discontinued Operations | 48 | |
Colony Capital | Supplemental Financial Report | 5 |
Colony Capital | Supplemental Financial Report | 6 |
Colony Capital | Supplemental Financial Report | 7 |
Colony Capital | Supplemental Financial Report | 8 |
Colony Capital | Supplemental Financial Report | 9 |
Colony Capital | Supplemental Financial Report | 10 |
Colony Capital | Supplemental Financial Report | 11 |
Colony Capital | Supplemental Financial Report | 12 |
Colony Capital | Supplemental Financial Report | 13 |
IIa. Financial Overview - Summary Metrics |
($ and shares in thousands, except per share data and as noted; as of or for the three months ended December 31, 2019, unless otherwise noted) (Unaudited) | |||
Financial Data | |||
Net income (loss) attributable to common stockholders | $ | (26,251 | ) |
Net income (loss) attributable to common stockholders per basic share | (0.06 | ) | |
Core FFO(1) | 47,590 | ||
Core FFO per basic share | 0.09 | ||
Q1 2020 dividend per share | 0.11 | ||
Annualized Q1 2020 dividend per share | 0.44 | ||
Balance Sheet, Capitalization and Trading Statistics | |||
Total consolidated assets | $ | 19,832,184 | |
CLNY OP share of consolidated assets | 13,678,097 | ||
Total consolidated debt(2) | 9,407,842 | ||
CLNY OP share of consolidated debt(2) | 6,835,312 | ||
Shares and OP units outstanding as of December 31, 2019 | 541,039 | ||
Shares and OP units outstanding as of February 25, 2020 | 540,631 | ||
Share price as of February 25, 2020 | 4.55 | ||
Market value of common equity & OP units as of February 25, 2020 | 2,459,871 | ||
Liquidation preference of perpetual preferred equity | 1,033,750 | ||
Insider ownership of shares and OP units as of February 25, 2020 | 9.5 | % | |
Total Assets Under Management ("AUM") | $ 49.0 billion | ||
Fee Earning Equity Under Management ("FEEUM") | $ 19.4 billion |
(1) | Fourth quarter 2019 Core FFO included net losses of $21.4 million. |
(2) | Represents principal balance and excludes debt issuance costs, discounts and premiums. |
Colony Capital | Supplemental Financial Report | 14 |
IIb. Financial Overview - Summary of Segments |
($ in thousands; as of or for the three months ended December 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||
Investment Management | ||||||
Third-party AUM ($ in millions) | $ | 36,286 | ||||
FEEUM ($ in millions)(1) | 19,440 | |||||
Q4 2019 fee revenue and REIM platform equity method earnings | 46,778 | |||||
Healthcare Real Estate | ||||||
Q4 2019 net operating income(2)(3) | 76,571 | 54,366 | ||||
Annualized net operating income(4) | 283,884 | 201,271 | ||||
Investment-level non-recourse financing(5) | 2,953,706 | 2,104,721 | ||||
Hospitality Real Estate | ||||||
Q4 2019 NOI before FF&E Reserve(3) | 54,129 | 50,827 | ||||
TTM NOI before FF&E Reserve(6) | 274,793 | 258,604 | ||||
Investment-level non-recourse financing(5) | 2,667,347 | 2,495,952 |
(1) | Subsequent to the fourth quarter 2019, the Company completed the sale of its 27.2% ownership interest in RXR Realty, which represents $1.9 billion of FEEUM. |
(2) | NOI includes $0.9 million consolidated or $0.7 million CLNY OP share of interest earned related to $43 million consolidated or $30 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended December 31, 2019. |
(3) | For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
(4) | Annualized NOI excludes an aggregate $5.6 million consolidated, or $4.0 million CLNY OP share, of fourth quarter 2019 one-time items from the recovery of tenant rent receivables from certain tenants in the Skilled Nursing Facilities, Triple-Net Lease Senior Housing Properties and Hospitals portfolios and termination fees in the Medical Office Buildings portfolio. |
(5) | Represents unpaid principal balance. |
(6) | TTM = trailing twelve month. |
Colony Capital | Supplemental Financial Report | 15 |
IIb. Financial Overview - Summary of Segments (cont’d) |
($ in thousands except as noted; as of or for the three months ended December 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
CLNC | ||||||||
Net carrying value of 36% interest | $ | 725,443 | $ | 725,443 | ||||
Other Equity and Debt (1) | ||||||||
1) Strategic Investments | ||||||||
a) Digital - direct investments and Digital Colony Partners GP co-investments - net carrying value | 954,754 | 232,891 | ||||||
b) GP Co-investments in CDCF IV and CDCF V investments - net carrying value | 1,617,815 | 280,848 | ||||||
c) Other GP co-investments - net carrying value | 365,664 | 356,029 | ||||||
2) Net lease real estate equity | ||||||||
a) Q4 2019 net operating income | 771 | 770 | ||||||
b) Investment-level non-recourse financing(2) | 104,061 | 103,441 | ||||||
3) Other real estate equity | ||||||||
a) Undepreciated carrying value of real estate assets(3) | 1,864,369 | 927,905 | ||||||
b) Investment-level non-recourse financing(2) | 1,237,397 | 614,299 | ||||||
c) Carrying value - equity method investments (including Albertsons) | 317,010 | 237,410 | ||||||
4) Real estate debt | ||||||||
a) Carrying value - consolidated | 300,825 | 214,573 | ||||||
b) Investment-level non-recourse financing(2) | — | — | ||||||
c) Carrying value - equity method investments | 11,160 | 6,089 | ||||||
d) Carrying value - real estate assets (REO within debt portfolio) and other(3) | 45,030 | 25,841 | ||||||
5) CRE securities and real estate PE fund investments | ||||||||
a) Carrying value | 60,251 | |||||||
Net Assets | ||||||||
Cash and cash equivalents, restricted cash and other assets(4) | 2,116,008 | 1,782,074 | ||||||
Accrued and other liabilities and dividends payable(5) | 1,410,867 | 1,118,468 | ||||||
Net assets | $ | 705,141 | $ | 663,606 |
(1) | Includes assets classified as held for sale on the Company’s financial statements. |
(2) | Represents unpaid principal balance. |
(3) | Includes all components related to real estate assets, including tangible real estate and lease-related intangibles, and excludes accumulated depreciation. |
(4) | Other assets excludes $3 million consolidated and CLNY OP share of deferred financing costs and $24 million consolidated or $13 million CLNY OP share of restricted cash which is included in the undepreciated carrying value of the hotel portfolio in Other Real Estate Equity shown on page 38. |
(5) | Accrued and other liabilities exclude $8 million consolidated and CLNY OP share of deferred tax liabilities and other liabilities which are not due in cash and $117 million of derivative liability which is included in the debt of Other GP Co-investments shown on page 37. |
Colony Capital | Supplemental Financial Report | 16 |
IIIa. Financial Results - Consolidated Balance Sheet |
($ in thousands, except per share data) | As of December 31, 2019 | |||
Assets | ||||
Cash and cash equivalents | $ | 1,205,190 | ||
Restricted cash | 203,923 | |||
Real estate, net | 10,860,518 | |||
Loans receivable, net | 1,552,824 | |||
Equity and debt investments | 2,313,805 | |||
Goodwill | 1,452,891 | |||
Deferred leasing costs and intangible assets, net | 638,853 | |||
Assets held for sale | 870,052 | |||
Other assets | 682,648 | |||
Due from affiliates | 51,480 | |||
Total assets | $ | 19,832,184 | ||
Liabilities | ||||
Debt, net | $ | 8,983,908 | ||
Accrued and other liabilities | 1,015,898 | |||
Intangible liabilities, net | 111,484 | |||
Liabilities related to assets held for sale | 268,152 | |||
Due to affiliates | 34,064 | |||
Dividends and distributions payable | 83,301 | |||
Preferred stock redemptions payable | 402,855 | |||
Total liabilities | 10,899,662 | |||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 6,107 | |||
Equity | ||||
Stockholders’ equity: | ||||
Preferred stock, $0.01 par value per share; $1,033,750 liquidation preference; 250,000 shares authorized; 41,350 shares issued and outstanding | 999,490 | |||
Common stock, $0.01 par value per share | ||||
Class A, 949,000 shares authorized; 487,044 shares issued and outstanding | 4,871 | |||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | 7 | |||
Additional paid-in capital | 7,553,599 | |||
Accumulated deficit | (3,389,592 | ) | ||
Accumulated other comprehensive income | 47,668 | |||
Total stockholders’ equity | 5,216,043 | |||
Noncontrolling interests in investment entities | 3,254,188 | |||
Noncontrolling interests in Operating Company | 456,184 | |||
Total equity | 8,926,415 | |||
Total liabilities, redeemable noncontrolling interests and equity | $ | 19,832,184 |
Colony Capital | Supplemental Financial Report | 17 |
IIIb. Financial Results - Noncontrolling Interests’ Share Balance Sheet |
($ in thousands, except per share data) (unaudited) | As of December 31, 2019 | |||
Assets | ||||
Cash and cash equivalents | $ | 114,224 | ||
Restricted cash | 35,865 | |||
Real estate, net | 3,300,115 | |||
Loans receivable, net | 779,143 | |||
Equity and debt investments | 650,980 | |||
Goodwill | 381,349 | |||
Deferred leasing costs and intangible assets, net | 247,446 | |||
Assets held for sale | 450,117 | |||
Other assets | 194,848 | |||
Total assets | $ | 6,154,087 | ||
Liabilities | ||||
Debt, net | $ | 2,419,539 | ||
Accrued and other liabilities | 292,399 | |||
Intangible liabilities, net | 47,004 | |||
Liabilities related to assets held for sale | 134,850 | |||
Total liabilities | 2,893,792 | |||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 6,107 | |||
Equity | ||||
Stockholders’ equity: | ||||
Preferred stock, $0.01 par value per share; $1,033,750 liquidation preference; 250,000 shares authorized; 41,350 shares issued and outstanding | — | |||
Common stock, $0.01 par value per share | ||||
Class A, 949,000 shares authorized; 487,044 shares issued and outstanding | — | |||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | — | |||
Additional paid-in capital | — | |||
Accumulated deficit | — | |||
Accumulated other comprehensive income | — | |||
Total stockholders’ equity | — | |||
Noncontrolling interests in investment entities | 3,254,188 | |||
Noncontrolling interests in Operating Company | — | |||
Total equity | 3,254,188 | |||
Total liabilities, redeemable noncontrolling interests and equity | $ | 6,154,087 |
Colony Capital | Supplemental Financial Report | 18 |
IIIc. Financial Results - Consolidated Segment Operating Results |
Three Months Ended December 31, 2019 | ||||||||||||||||||||||||||||||||
($ in thousands) (Unaudited) | Investment Management | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Amounts not allocated to segments | Total | ||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||||||
Property operating income | $ | — | $ | 153,099 | $ | — | $ | 186,423 | $ | — | $ | 107,046 | $ | — | $ | 446,568 | ||||||||||||||||
Interest income | 75 | 932 | — | — | — | 43,324 | 1,078 | 45,409 | ||||||||||||||||||||||||
Fee income | 45,600 | — | — | — | — | — | — | 45,600 | ||||||||||||||||||||||||
Other income | 7,182 | 347 | — | 27 | — | 4,329 | 2,899 | 14,784 | ||||||||||||||||||||||||
Total revenues | 52,857 | 154,378 | — | 186,450 | — | 154,699 | 3,977 | 552,361 | ||||||||||||||||||||||||
Expenses | ||||||||||||||||||||||||||||||||
Property operating expense | — | 66,106 | — | 132,710 | — | 67,760 | — | 266,576 | ||||||||||||||||||||||||
Interest expense | 1,645 | 41,930 | — | 45,484 | — | 26,537 | 13,281 | 128,877 | ||||||||||||||||||||||||
Investment and servicing expense | 81 | 3,137 | — | 1,787 | — | 19,967 | 1,724 | 26,696 | ||||||||||||||||||||||||
Transaction costs | 319 | — | — | — | — | 366 | — | 685 | ||||||||||||||||||||||||
Placement fees | 1,429 | — | — | — | — | — | — | 1,429 | ||||||||||||||||||||||||
Depreciation and amortization | 8,697 | 41,208 | — | 36,035 | — | 22,612 | 1,501 | 110,053 | ||||||||||||||||||||||||
Provision for loan loss | — | — | — | — | — | 33 | — | 33 | ||||||||||||||||||||||||
Impairment loss | 410,954 | 43,132 | — | 14,649 | — | 2,492 | — | 471,227 | ||||||||||||||||||||||||
Compensation expense | ||||||||||||||||||||||||||||||||
Cash and equity-based compensation | 20,382 | 1,597 | — | 1,615 | — | 4,652 | 25,590 | 53,836 | ||||||||||||||||||||||||
Carried interest and incentive compensation | 3,300 | — | — | — | — | — | — | 3,300 | ||||||||||||||||||||||||
Administrative expenses | 4,765 | 885 | — | 481 | — | 7,135 | 12,546 | 25,812 | ||||||||||||||||||||||||
Total expenses | 451,572 | 197,995 | — | 232,761 | — | 151,554 | 54,642 | 1,088,524 | ||||||||||||||||||||||||
Other income (loss) | ||||||||||||||||||||||||||||||||
Gain on sale of real estate assets | — | 551 | — | — | — | 18,611 | — | 19,162 | ||||||||||||||||||||||||
Other gain (loss), net | 738 | 5,690 | — | 1,492 | — | (16,489 | ) | (1,596 | ) | (10,165 | ) | |||||||||||||||||||||
Equity method earnings (loss) | (613 | ) | — | — | — | 13,064 | 25,613 | — | 38,064 | |||||||||||||||||||||||
Equity method earnings—carried interest | 5,424 | — | — | — | — | — | — | 5,424 | ||||||||||||||||||||||||
Income (loss) before income taxes | (393,166 | ) | (37,376 | ) | — | (44,819 | ) | 13,064 | 30,880 | (52,261 | ) | (483,678 | ) | |||||||||||||||||||
Income tax benefit (expense) | 3,241 | (1,232 | ) | — | 1,700 | — | (3,695 | ) | (266 | ) | (252 | ) | ||||||||||||||||||||
Income (loss) from continuing operations | (389,925 | ) | (38,608 | ) | — | (43,119 | ) | 13,064 | 27,185 | (52,527 | ) | (483,930 | ) | |||||||||||||||||||
Income (loss) from discontinued operations | (10,561 | ) | — | 1,426,219 | — | — | — | — | 1,415,658 | |||||||||||||||||||||||
Net income (loss) | (400,486 | ) | (38,608 | ) | 1,426,219 | (43,119 | ) | 13,064 | 27,185 | (52,527 | ) | 931,728 | ||||||||||||||||||||
Net income (loss) attributable to noncontrolling interests: | ||||||||||||||||||||||||||||||||
Redeemable noncontrolling interests | — | — | — | — | — | 242 | — | 242 | ||||||||||||||||||||||||
Investment entities | (28,531 | ) | (4,107 | ) | 943,647 | (3,816 | ) | — | 31,423 | — | 938,616 | |||||||||||||||||||||
Operating Company | (36,305 | ) | (3,366 | ) | 47,078 | (3,834 | ) | 1,275 | (438 | ) | (7,277 | ) | (2,867 | ) | ||||||||||||||||||
Net income (loss) attributable to Colony Capital, Inc. | (335,650 | ) | (31,135 | ) | 435,494 | (35,469 | ) | 11,789 | (4,042 | ) | (45,250 | ) | (4,263 | ) | ||||||||||||||||||
Preferred stock redemption | — | — | — | — | — | — | (5,150 | ) | (5,150 | ) | ||||||||||||||||||||||
Preferred stock dividends | — | — | — | — | — | — | 27,138 | 27,138 | ||||||||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (335,650 | ) | $ | (31,135 | ) | $ | 435,494 | $ | (35,469 | ) | $ | 11,789 | $ | (4,042 | ) | $ | (67,238 | ) | $ | (26,251 | ) |
Colony Capital | Supplemental Financial Report | 19 |
IIId. Financial Results - Noncontrolling Interests’ Share Segment Operating Results |
Three Months Ended December 31, 2019 | |||||||||||||||||||||||||||||||||
($ in thousands) (unaudited) | Investment Management | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Amounts not allocated to segments | Total | |||||||||||||||||||||||||
Revenues | — | ||||||||||||||||||||||||||||||||
Property operating income | $ | — | $ | 43,486 | $ | — | $ | 11,673 | $ | — | $ | 56,532 | $ | — | $ | 111,691 | |||||||||||||||||
Interest income | — | 279 | — | — | — | 24,167 | — | 24,446 | |||||||||||||||||||||||||
Fee income | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Other income | — | 71 | — | 4 | — | 1,699 | — | 1,774 | |||||||||||||||||||||||||
Total revenues | — | 43,836 | — | 11,677 | — | 82,398 | — | 137,911 | |||||||||||||||||||||||||
Expenses | |||||||||||||||||||||||||||||||||
Property operating expense | — | 18,237 | — | 8,558 | — | 33,610 | — | 60,405 | |||||||||||||||||||||||||
Interest expense | — | 11,966 | — | 3,167 | — | 12,489 | — | 27,622 | |||||||||||||||||||||||||
Investment and servicing expense | — | 854 | — | 137 | — | 9,824 | — | 10,815 | |||||||||||||||||||||||||
Transaction costs | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Placement fees | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Depreciation and amortization | — | 11,877 | — | 2,342 | — | 13,319 | — | 27,538 | |||||||||||||||||||||||||
Provision for loan loss | — | — | — | — | — | 27 | — | 27 | |||||||||||||||||||||||||
Impairment loss | — | 9,857 | — | 1,254 | — | 3,582 | — | 14,693 | |||||||||||||||||||||||||
Compensation expense | |||||||||||||||||||||||||||||||||
Cash and equity-based compensation | — | — | — | — | — | 2,581 | — | 2,581 | |||||||||||||||||||||||||
Carried interest and incentive compensation | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Administrative expenses | — | 246 | — | 21 | — | 4,141 | — | 4,408 | |||||||||||||||||||||||||
Total expenses | — | 53,037 | — | 15,479 | — | 79,573 | — | 148,089 | |||||||||||||||||||||||||
Other income (loss) | |||||||||||||||||||||||||||||||||
Gain on sale of real estate assets | — | 103 | — | — | — | 14,295 | — | 14,398 | |||||||||||||||||||||||||
Other gain (loss), net | — | 1,727 | — | (14 | ) | — | (3,175 | ) | — | (1,462 | ) | ||||||||||||||||||||||
Equity method earnings (losses) | 145 | — | — | — | — | 19,845 | — | 19,990 | |||||||||||||||||||||||||
Equity method earnings—carried interest | (596 | ) | — | — | — | — | — | — | (596 | ) | |||||||||||||||||||||||
Income (loss) before income taxes | (451 | ) | (7,371 | ) | — | (3,816 | ) | — | 33,790 | — | 22,152 | ||||||||||||||||||||||
Income tax benefit (expense) | — | (439 | ) | — | — | — | (2,125 | ) | — | (2,564 | ) | ||||||||||||||||||||||
Net income (loss) | (451 | ) | (7,810 | ) | — | (3,816 | ) | — | 31,665 | — | 19,588 | ||||||||||||||||||||||
Income (loss) from discontinued operations | — | — | 943,647 | — | — | — | — | 943,647 | |||||||||||||||||||||||||
Non-pro rata allocation of income (loss) to NCI | (28,080 | ) | 3,703 | — | — | — | — | — | (24,377 | ) | |||||||||||||||||||||||
Net income (loss) attributable to noncontrolling interests | $ | (28,531 | ) | $ | (4,107 | ) | $ | 943,647 | $ | (3,816 | ) | $ | — | $ | 31,665 | $ | — | $ | 938,858 |
Colony Capital | Supplemental Financial Report | 20 |
IIIe. Financial Results - Segment Reconciliation of Net Income to FFO & Core FFO |
Three Months Ended December 31, 2019 | ||||||||||||||||||||||||||||||||||||||||
OP pro rata share by segment | Amounts attributable to noncontrolling interests | CLNY consolidated as reported | ||||||||||||||||||||||||||||||||||||||
($ in thousands) (Unaudited) | Investment Management | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Amounts not allocated to segments | Total OP pro rata share | ||||||||||||||||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (335,650 | ) | $ | (31,135 | ) | $ | 435,494 | $ | (35,469 | ) | $ | 11,789 | $ | (4,042 | ) | $ | (67,238 | ) | $ | (26,251 | ) | $ | — | $ | (26,251 | ) | |||||||||||||
Net income (loss) attributable to noncontrolling common interests in Operating Company | (36,305 | ) | (3,366 | ) | 47,078 | (3,834 | ) | 1,275 | (438 | ) | (7,277 | ) | (2,867 | ) | — | (2,867 | ) | |||||||||||||||||||||||
Net income (loss) attributable to common interests in Operating Company and common stockholders | (371,955 | ) | (34,501 | ) | 482,572 | (39,303 | ) | 13,064 | (4,480 | ) | (74,515 | ) | (29,118 | ) | — | (29,118 | ) | |||||||||||||||||||||||
Adjustments for FFO: | ||||||||||||||||||||||||||||||||||||||||
Real estate depreciation and amortization | 1,729 | 30,807 | 3,205 | 33,693 | 7,397 | 9,471 | — | 86,302 | 31,951 | 118,253 | ||||||||||||||||||||||||||||||
Impairment of real estate | — | 33,275 | — | 13,395 | — | (1,090 | ) | — | 45,580 | 14,693 | 60,273 | |||||||||||||||||||||||||||||
Gain from sales of real estate | — | (448 | ) | (486,874 | ) | — | — | (4,372 | ) | — | (491,694 | ) | (957,346 | ) | (1,449,040 | ) | ||||||||||||||||||||||||
Less: Adjustments attributable to noncontrolling interests in investment entities | — | — | — | — | — | — | — | — | 910,702 | 910,702 | ||||||||||||||||||||||||||||||
FFO | $ | (370,226 | ) | $ | 29,133 | $ | (1,097 | ) | $ | 7,785 | $ | 20,461 | $ | (471 | ) | $ | (74,515 | ) | $ | (388,930 | ) | $ | — | $ | (388,930 | ) | ||||||||||||||
Additional adjustments for Core FFO: | ||||||||||||||||||||||||||||||||||||||||
Gains and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO(1) | — | — | — | — | — | (5,264 | ) | — | (5,264 | ) | 5,901 | 637 | ||||||||||||||||||||||||||||
Gains and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment | 409,426 | — | (9,427 | ) | — | — | — | — | 399,999 | — | 399,999 | |||||||||||||||||||||||||||||
CLNC Core Earnings adjustments(2) | — | — | — | — | (5,401 | ) | — | — | (5,401 | ) | — | (5,401 | ) | |||||||||||||||||||||||||||
Equity-based compensation expense | 2,666 | 539 | 6,035 | 545 | 1,218 | 421 | 8,730 | 20,154 | — | 20,154 | ||||||||||||||||||||||||||||||
Straight-line rent revenue and expense | 255 | (1,586 | ) | (906 | ) | 280 | — | (669 | ) | (526 | ) | (3,152 | ) | (2,583 | ) | (5,735 | ) | |||||||||||||||||||||||
Amortization of acquired above- and below-market lease values, net | — | (6,303 | ) | (268 | ) | — | (144 | ) | (29 | ) | — | (6,744 | ) | (3,247 | ) | (9,991 | ) | |||||||||||||||||||||||
Amortization of deferred financing costs and debt premiums and discounts | 102 | 1,915 | 9,275 | 10,424 | (2 | ) | 2,487 | 1,734 | 25,935 | 23,318 | 49,253 | |||||||||||||||||||||||||||||
Unrealized fair value losses on interest rate and foreign currency hedges, and foreign currency remeasurements and realized gains and losses on interest rate hedging instruments existing at the time of the January 2017 merger with remaining terms greater than one year that served as economic hedges for any financing or refinancing of the Company's real estate verticals | (15 | ) | (4,113 | ) | — | — | (716 | ) | 1,072 | 1,745 | (2,027 | ) | 1,138 | (889 | ) | |||||||||||||||||||||||||
Acquisition and merger-related transaction costs | 319 | — | — | (1,629 | ) | — | 366 | — | (944 | ) | — | (944 | ) | |||||||||||||||||||||||||||
Restructuring and merger integration costs(3) | 1,070 | — | 11,559 | — | — | — | 4,055 | 16,684 | — | 16,684 | ||||||||||||||||||||||||||||||
Amortization and impairment of investment management intangibles | 8,640 | — | — | — | — | — | — | 8,640 | — | 8,640 | ||||||||||||||||||||||||||||||
Non-real estate depreciation and amortization | 36 | — | 30 | — | — | 85 | 1,500 | 1,651 | 271 | 1,922 | ||||||||||||||||||||||||||||||
Amortization of gain on remeasurement of consolidated investment entities | — | — | — | — | — | 3 | — | 3 | 3 | 6 | ||||||||||||||||||||||||||||||
Tax effect of Core FFO adjustments, net | (3,333 | ) | — | (3,575 | ) | — | — | — | (956 | ) | (7,864 | ) | — | (7,864 | ) | |||||||||||||||||||||||||
Preferred share redemption gain | — | — | — | — | — | — | (5,150 | ) | (5,150 | ) | — | (5,150 | ) | |||||||||||||||||||||||||||
Less: Adjustments attributable to noncontrolling interests in investment entities | — | — | — | — | — | — | — | — | (24,801 | ) | (24,801 | ) | ||||||||||||||||||||||||||||
Core FFO | $ | 48,940 | $ | 19,585 | $ | 11,626 | $ | 17,405 | $ | 15,416 | $ | (1,999 | ) | $ | (63,383 | ) | $ | 47,590 | $ | — | $ | 47,590 |
(1) | Net of $18.0 million consolidated or $9.6 million CLNY OP share of depreciation, amortization and impairment charges previously adjusted to calculate FFO. |
(2) | Represents adjustments to align the Company’s Core FFO with CLNC’s definition of Core Earnings to reflect the Company’s percentage interest in CLNC's earnings. |
(3) | Restructuring and merger integration costs primarily represent costs and charges incurred as a result of the corporate restructuring and reorganization plan announced in November 2018 and the implementation of the digital evolution, including the completed sale of the Industrial business, NorthStar Realty Europe and future sales and disposition of non-digital businesses, platforms and investments. These costs and charges include severance, retention, relocation, transition and other related restructuring costs, which are not reflective of the Company’s core operating performance and the Company does not expect to incur these costs subsequent to the completion of the corporate restructuring and reorganization plan and the digital evolution. |
Colony Capital | Supplemental Financial Report | 21 |
IVa. Capitalization - Overview |
($ in thousands; except per share data; as of December 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | |||||||||
Debt (UPB) | |||||||||||
$750,000 Revolving credit facility | $ | — | $ | — | |||||||
Convertible/exchangeable senior notes | 616,105 | 616,105 | |||||||||
Corporate aircraft promissory note | 35,072 | 35,072 | |||||||||
Trust Preferred Securities ("TruPS") | 280,117 | 280,117 | |||||||||
Investment-level debt: | |||||||||||
Healthcare | 2,953,706 | 2,104,721 | |||||||||
Industrial | 235,000 | 119,850 | |||||||||
Hospitality | 2,667,347 | 2,495,952 | |||||||||
Other Equity and Debt(1) | 2,620,495 | 1,183,495 | |||||||||
Total investment-level debt | 8,476,548 | 5,904,018 | |||||||||
Total debt | $ | 9,407,842 | $ | 6,835,312 | |||||||
Perpetual preferred equity, redemption value | |||||||||||
Total perpetual preferred equity(2) | $ | 1,033,750 | |||||||||
Common equity as of February 25, 2020 | Price per share | Shares / Units | |||||||||
Class A and B common stock | $ | 4.55 | 487,370 | $ | 2,217,534 | ||||||
OP units | 4.55 | 53,261 | 242,338 | ||||||||
Total market value of common equity | $ | 2,459,872 | |||||||||
Total market capitalization | $ | 10,328,934 |
(1) | In December 2019, the Company made its inaugural direct balance sheet investment in digital real estate by acquiring a 20.4% interest in DataBank. Debt related to Databank of $539 million consolidated or $110 million CLNY OP share is included in Other Equity and Debt. |
(2) | On January 10, 2020, the Company redeemed all of its outstanding 8.25% Series B and 8.75% Series E cumulative redeemable perpetual preferred stock for $408 million, including accrued interest of $5 million, eliminating $34 million of annualized preferred dividends. |
Colony Capital | Supplemental Financial Report | 22 |
IVb. Capitalization - Investment-Level Debt Overview |
($ in thousands; as of or for the three months ended December 31, 2019, unless otherwise noted) | ||||||||||||||||
Non-recourse investment-level debt overview | ||||||||||||||||
Consolidated | CLNY OP share of consolidated amount | |||||||||||||||
Fixed / Floating | Unpaid principal balance | Unpaid principal balance | Wtd. avg. years remaining to maturity | Wtd. avg. interest rate(1) | ||||||||||||
Healthcare | Fixed | $ | 405,980 | $ | 285,039 | 5.1 | 4.5 | % | ||||||||
Healthcare | Floating | 2,547,726 | 1,819,682 | 4.3 | 5.2 | % | ||||||||||
Bulk Industrial | Floating | 235,000 | 119,850 | 4.2 | 3.8 | % | ||||||||||
Hospitality | Fixed | 13,494 | 13,156 | 1.6 | 12.7 | % | ||||||||||
Hospitality | Floating | 2,653,853 | 2,482,796 | 4.6 | 4.8 | % | ||||||||||
Other Equity and Debt | ||||||||||||||||
Net lease real estate equity | Fixed | 104,061 | 103,441 | 3.4 | 5.0 | % | ||||||||||
Other real estate equity | Fixed | 45,979 | 13,221 | 3.2 | 2.8 | % | ||||||||||
Other real estate equity | Floating | 1,191,418 | 601,078 | 2.8 | 4.6 | % | ||||||||||
GP Co-investments(2) | Floating | 1,277,300 | 465,409 | 2.8 | 4.5 | % | ||||||||||
GP Co-investments | Fixed | 1,737 | 346 | 3.6 | 2.4 | % | ||||||||||
Total investment-level debt | $ | 8,476,548 | $ | 5,904,018 | 4.2 | 4.9 | % | |||||||||
Fixed / Floating Summary | ||||||||||||||||
Fixed | $ | 571,251 | $ | 415,203 | ||||||||||||
Floating | 7,905,297 | 5,488,815 | ||||||||||||||
Total investment-level debt | $ | 8,476,548 | $ | 5,904,018 |
(1) | Based on 1-month LIBOR of 1.76% and 3-month LIBOR of 1.91% for floating rate debt. |
(2) | In December 2019, the Company made its inaugural direct balance sheet investment in digital real estate by acquiring a 20.4% interest in DataBank. Debt related to Databank of $539 million consolidated or $110 million CLNY OP share is included in Other Equity and Debt. |
Colony Capital | Supplemental Financial Report | 23 |
IVc. Capitalization - Revolving Credit Facility Overview |
($ in thousands, except as noted; as of December 31, 2019) | ||||
Revolving credit facility | ||||
Maximum principal amount | $ | 750,000 | ||
Amount outstanding | — | |||
Initial maturity | January 11, 2021 | |||
Fully-extended maturity | January 10, 2022 | |||
Interest rate | LIBOR + 2.25% | |||
Financial covenants as defined in the Credit Agreement: | Covenant level | |||
Consolidated Tangible Net Worth | Minimum $4,550 million | |||
Consolidated Fixed Charge Coverage Ratio(1) | Minimum 1.30 to 1.00 | |||
Interest Coverage Ratio(2) | Minimum 3.00 to 1.00 | |||
Consolidated Leverage Ratio | Maximum 0.65 to 1.00 | |||
Company status: As of December 31, 2019, CLNY is meeting all required covenant threshold levels |
(1) | In the event the Fixed Charge Coverage Ratio is between 1.50 and 1.30 to 1.00, the borrowing base formula will be discounted by 10%. |
(2) | Interest Coverage Ratio represents the ratio of the sum of (1) earnings from borrowing base assets and (2) certain investment management earnings divided by the greater of (a) actual interest expense on the revolving credit facility and (b) the average balance of the facility multiplied by 7.0% for the applicable quarter. |
Colony Capital | Supplemental Financial Report | 24 |
IVd. Capitalization - Corporate Securities Overview |
($ in thousands; except per share data; as of December 31, 2019, unless otherwise noted) | ||||||||||||||||||
Convertible/exchangeable debt | ||||||||||||||||||
Description | Outstanding principal | Final due date(1) | Interest rate | Conversion price (per share of common stock) | Conversion ratio | Conversion shares | ||||||||||||
5.0% Convertible senior notes | $ | 200,000 | April 15, 2023 | 5.00% fixed | $ | 15.76 | 63.4700 | 12,694 | ||||||||||
3.875% Convertible senior notes | 402,500 | January 15, 2021 | 3.875% fixed | 16.57 | 60.3431 | 24,288 | ||||||||||||
5.375% Exchangeable senior notes | 13,605 | June 15, 2033 | 5.375% fixed | 12.04 | 83.0837 | 1,130 | ||||||||||||
Total convertible debt | $ | 616,105 |
TruPS | ||||||||
Description | Outstanding principal | Final due date | Interest rate | |||||
Trust I | $ | 41,240 | March 30, 2035 | 3M L + 3.25% | ||||
Trust II | 25,780 | June 30, 2035 | 3M L + 3.25% | |||||
Trust III | 41,238 | January 30, 2036 | 3M L + 2.83% | |||||
Trust IV | 50,100 | June 30, 2036 | 3M L + 2.80% | |||||
Trust V | 30,100 | September 30, 2036 | 3M L + 2.70% | |||||
Trust VI | 25,100 | December 30, 2036 | 3M L + 2.90% | |||||
Trust VII | 31,459 | April 30, 2037 | 3M L + 2.50% | |||||
Trust VIII | 35,100 | July 30, 2037 | 3M L + 2.70% | |||||
Total TruPS | $ | 280,117 |
Perpetual preferred stock | |||||||||
Description | Liquidation preference | Shares outstanding (In thousands) | Callable period | ||||||
Series G 7.5% cumulative redeemable perpetual preferred stock | 86,250 | 3,450 | Callable | ||||||
Series H 7.125% cumulative redeemable perpetual preferred stock | 287,500 | 11,500 | On or after April 13, 2020 | ||||||
Series I 7.15% cumulative redeemable perpetual preferred stock | 345,000 | 13,800 | On or after June 5, 2022 | ||||||
Series J 7.125% cumulative redeemable perpetual preferred stock | 315,000 | 12,600 | On or after September 22, 2022 | ||||||
Total preferred stock | $ | 1,033,750 | 41,350 |
(1) | Callable at principal amount only if CLNY common stock has traded at least 130% of the conversion price for 20 of 30 consecutive trading days: on or after April 22, 2020, for the 5.0% convertible senior notes; on or after January 22, 2019, for the 3.875% convertible senior notes; and on or after on or after June 15, 2020, for the 5.375% exchangeable senior notes. |
Colony Capital | Supplemental Financial Report | 25 |
IVe. Capitalization - Debt Maturity and Amortization Schedules |
($ in thousands; as of December 31, 2019) | Payments due by period(1) | |||||||||||||||||||||||
Consolidated debt | Fixed / Floating | 2020 | 2021 | 2022 | 2023 | 2024 and after | Total | |||||||||||||||||
$750,000 Revolving credit facility | Floating | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||
Convertible/exchangeable senior notes | Fixed | — | 402,500 | — | 200,000 | 13,605 | 616,105 | |||||||||||||||||
Corporate aircraft promissory note | Fixed | 2,243 | 2,359 | 2,480 | 2,608 | 25,382 | 35,072 | |||||||||||||||||
TruPS | Floating | — | — | — | — | 280,117 | 280,117 | |||||||||||||||||
Investment-level debt: | ||||||||||||||||||||||||
Healthcare | Fixed | 6,809 | 8,083 | 9,068 | 9,510 | 372,510 | 405,980 | |||||||||||||||||
Healthcare | Floating | 53,914 | 284,059 | 7,891 | 8,129 | 2,193,733 | 2,547,726 | |||||||||||||||||
Bulk Industrial | Floating | — | — | — | — | 235,000 | 235,000 | |||||||||||||||||
Hospitality | Fixed | — | 13,494 | — | — | — | 13,494 | |||||||||||||||||
Hospitality | Floating | — | 206,802 | 780,000 | — | 1,667,051 | 2,653,853 | |||||||||||||||||
Other Equity and Debt | Fixed | 13,435 | 35,025 | 19,572 | 80,389 | 3,356 | 151,777 | |||||||||||||||||
Other Equity and Debt | Floating | 316,940 | 199,546 | 992,504 | 33,879 | 925,849 | 2,468,718 | |||||||||||||||||
Total consolidated debt | $ | 393,341 | $ | 1,151,868 | $ | 1,811,515 | $ | 334,515 | $ | 5,716,603 | $ | 9,407,842 | ||||||||||||
Pro rata debt | Fixed / Floating | 2020 | 2021 | 2022 | 2023 | 2024 and after | Total | |||||||||||||||||
$750,000 Revolving credit facility | Floating | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||
Convertible/exchangeable senior notes | Fixed | — | 402,500 | — | 200,000 | 13,605 | 616,105 | |||||||||||||||||
Corporate aircraft promissory note | Fixed | 2,243 | 2,359 | 2,480 | 2,608 | 25,382 | 35,072 | |||||||||||||||||
TruPS | Floating | — | — | — | — | 280,117 | 280,117 | |||||||||||||||||
Investment-level debt: | ||||||||||||||||||||||||
Healthcare | Fixed | 4,781 | 5,675 | 6,366 | 6,677 | 261,540 | 285,039 | |||||||||||||||||
Healthcare | Floating | 38,264 | 227,548 | 5,601 | 5,774 | 1,542,495 | 1,819,682 | |||||||||||||||||
Bulk Industrial | Floating | — | — | — | — | 119,850 | 119,850 | |||||||||||||||||
Hospitality | Fixed | — | 13,156 | — | — | — | 13,156 | |||||||||||||||||
Hospitality | Floating | — | 201,632 | 702,000 | — | 1,579,164 | 2,482,796 | |||||||||||||||||
Other Equity and Debt | Fixed | 4,892 | 26,438 | 6,739 | 77,820 | 1,119 | 117,008 | |||||||||||||||||
Other Equity and Debt | Floating | 105,067 | 191,303 | 513,720 | 7,148 | 249,249 | 1,066,487 | |||||||||||||||||
Total pro rata debt | $ | 155,247 | $ | 1,070,611 | $ | 1,236,906 | $ | 300,027 | $ | 4,072,521 | $ | 6,835,312 |
(1) | Based on initial maturity dates or extended maturity dates to the extent criteria are met and the extension option is at the borrower’s discretion. |
Colony Capital | Supplemental Financial Report | 26 |
Va. Investment Management - Summary Metrics |
($ in thousands, except as noted; as of December 31, 2019) | ||||
Fee Revenue | CLNY OP Share | |||
Digital Bridge Holdings | $ | 18,347 | ||
Institutional funds | 13,983 | |||
Colony Credit Real Estate (NYSE:CLNC) | 8,273 | |||
Retail companies | 4,997 | |||
Non-wholly owned REIM platforms (equity method earnings) | 1,178 | |||
Total reported fee revenue and REIM platform equity method earnings | $ | 46,778 | ||
Operating Results | ||||
Revenues | ||||
Total fee revenue and REIM earnings of investments in unconsolidated ventures | $ | 46,778 | ||
Interest Income and Other Income | 7,257 | |||
Expenses | ||||
Interest expense | 1,645 | |||
Investment and servicing expense | 81 | |||
Transaction costs | 319 | |||
Placement fees | 1,429 | |||
Depreciation and amortization | 8,697 | |||
(Recovery of) impairment loss(1) | 410,954 | |||
Compensation expense | ||||
Cash and equity-based compensation | 20,382 | |||
Carried interest and incentive compensation | 3,300 | |||
Administrative expenses | 4,765 | |||
Total expenses | 451,572 | |||
Other gain (loss), net | 738 | |||
Equity method earnings | (1,936 | ) | ||
Equity method earnings—carried interest | 6,020 | |||
Income tax benefit (expense) | 3,241 | |||
Income (loss) from discontinued operations(2)(3) | (10,561 | ) | ||
Non-pro rata allocation of income (loss) to NCI(3) | 28,080 | |||
Net loss attributable to common interests in OP and common stockholders | (371,955 | ) | ||
Real estate depreciation and amortization | 1,729 | |||
(Gains) and losses from sales of businesses and impairment write-downs associated with the Investment Management segment | 409,426 | |||
Equity-based compensation expense | 2,666 | |||
Straight-line rent revenue and expense | 255 | |||
Amortization of deferred financing costs and debt premiums and discounts | 102 | |||
Unrealized fair value losses on interest rate and foreign currency hedges, and foreign currency remeasurements | (15 | ) | ||
Acquisition and merger-related transaction costs | 319 | |||
Restructuring and merger integration costs | 1,070 | |||
Amortization and impairment of investment management intangibles | 8,640 | |||
Non-real estate depreciation and amortization | 36 | |||
Tax effect of Core FFO adjustments, net | (3,333 | ) | ||
Core FFO | $ | 48,940 |
Colony Capital | Supplemental Financial Report | 27 |
Va. Investment Management - Summary Metrics |
(1) | Represents a $401 million write-down of goodwill resulting from a reduction in value of the non-digital investment management business and a $10 million write-down of contract intangibles. Reduction of goodwill and contract intangibles are added back to the Company's net loss to calculate Core FFO. |
(2) | In December 2019, the Company completed the sale of its light industrial portfolio and related operating platform. Accordingly, for all current and prior periods presented, the related operating results are presented as income from discontinued operations on the consolidated statement of operations. |
(3) | Net loss and Core FFO included $17 million of realized incentive fees, which is net of related compensation expenses, from the sale of the light industrial portfolio and related operating platform. |
Colony Capital | Supplemental Financial Report | 28 |
Vb. Investment Management – Assets Under Management |
($ in millions, except as noted; as of December 31, 2019, unless otherwise noted) | |||||||||||||||
Segment | Products (FEEUM) | Description | AUM CLNY OP Share | FEEUM CLNY OP Share | Fee Rate | ||||||||||
Digital | • Digital ($6.8 billion) | • Leading global investment manager of digital infrastructure assets including cell towers, small cells, fiber and data centers • Manager of six portfolio companies through separate partnerships • Manager of Digital Colony Partners Fund | $ | 13,502 | $ | 6,788 | 1.0 | % | |||||||
Other Institutional Funds | • Credit ($2.5 billion) • Opportunistic ($0.5 billion) • Other co-investment vehicles ($2.7 billion) | • 27 years of institutional investment management experience • Sponsorship of private equity funds and vehicles earning asset management fees and performance fees • More than 300 investor relationships | 8,500 | 5,654 | .8 | % | |||||||||
Public Company | • Colony Credit Real Estate, Inc. ($2.2 billion) | • NYSE-listed credit focused REIT • Contract with base management fees with potential for incentive fees | 3,523 | 2,181 | 1.5 | % | |||||||||
Retail Companies | • NorthStar Healthcare ($1.2 billion)(1) • CC Real Estate Income Funds(2)(3) | • Manage public non-traded vehicles earning asset management and performance fees | 3,432 | 1,211 | (1) | 1.5 | % | ||||||||
Non-Wholly Owned REIM Platforms | • RXR Realty • Alpine Energy • American Healthcare Investors | • CLNY recognizes at-share earnings from underlying non-wholly owned REIM platforms • 27% investment in RXR Realty, a real estate owner, developer and investment management company with $21 billion of AUM(4) • Alpine Energy, the Company's upstream energy investment management platform, jointly owned in partnership with Equity Group Investments • 43% investment in American Healthcare Investors, a healthcare investment management firm and sponsor of non-traded vehicles with $3 billion of AUM | 7,329 | 3,606 | N/A | ||||||||||
Total | $ | 36,286 | $ | 19,440 |
(1) | FEEUM of NorthStar Healthcare Income represents its most recently published Net Asset Value. |
(2) | CC Real Estate Income Funds represents a master/feeder structure and pools investor capital raised through three feeder funds. |
(3) | In February 2019, the board of directors of CC Real Estate Income Fund approved a plan to dissolve, liquidate and terminate CCREIF and distribute the net proceeds of such liquidation to its shareholders. There is no assurances to the timing or completion of the liquidation. |
(4) | Subsequent to the fourth quarter 2019, the Company completed the sale of its 27.2% ownership interest in RXR Realty. |
Colony Capital | Supplemental Financial Report | 29 |
VIa. Healthcare Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended December 31, 2019, unless otherwise noted) | Consolidated amount(1) | CLNY OP share of consolidated amount(1)(2) | ||||||
Net operating income | ||||||||
Net operating income: | ||||||||
Senior Housing - Operating | $ | 15,662 | $ | 11,120 | ||||
Medical Office Buildings | 13,853 | 9,836 | ||||||
Triple-Net Lease: | ||||||||
Senior Housing(3) | 16,087 | 11,422 | ||||||
Skilled Nursing Facilities | 24,411 | 17,332 | ||||||
Hospitals | 6,558 | 4,656 | ||||||
Total net operating income | $ | 76,571 | $ | 54,366 |
Portfolio overview | Total number of properties | Capacity | % Occupied(4) | TTM Lease Coverage(5) | WA Remaining Lease Term | ||||||||
Senior Housing - Operating | 83 | 6,388 units | 86.5 | % | N/A | N/A | |||||||
Medical Office Buildings | 106 | 3.8 million sq. ft. | 82.2 | % | N/A | 4.8 | |||||||
Triple-Net Lease: | |||||||||||||
Senior Housing | 71 | 4,039 units | 80.7 | % | 1.3x | 11.5 | |||||||
Skilled Nursing Facilities | 89 | 10,601 beds | 82.7 | % | 1.2x | 5.8 | |||||||
Hospitals | 9 | 456 beds | 58.0 | % | 3.0x | 5.5 | |||||||
Total | 358 |
Same store financial/operating results related to the segment | ||||||||||||||||||||||
% Occupied(4) | TTM Lease Coverage(5) | NOI(1) | ||||||||||||||||||||
Q4 2019 | Q3 2019 | 9/30/2019 | 6/30/2019 | Q4 2019 | Q3 2019 | % Change | ||||||||||||||||
Senior Housing - Operating | 86.5 | % | 86.2 | % | N/A | N/A | $ | 15,662 | $ | 15,611 | 0.3 | % | ||||||||||
Medical Office Buildings | 82.2 | % | 82.2 | % | N/A | N/A | 13,853 | 12,923 | 7.2 | % | ||||||||||||
Triple-Net Lease: | ||||||||||||||||||||||
Senior Housing | 79.7 | % | 79.8 | % | 1.3x | 1.3x | 15,765 | 13,833 | 14.0 | % | ||||||||||||
Skilled Nursing Facilities | 82.7 | % | 82.5 | % | 1.2x | 1.2x | 24,411 | 23,398 | 4.3 | % | ||||||||||||
Hospitals | 65.3 | % | 61.3 | % | 1.3x | 1.3x | 4,263 | 808 | 427.6 | % | ||||||||||||
Total | $ | 73,954 | $ | 66,573 | 11.1 | % |
(1) | Fourth quarter 2019 NOI included an aggregate $5.6 million consolidated, or $4.0 million CLNY OP share, of one-time recovery of tenant rent receivables from certain tenants in the Skilled Nursing Facilities, Triple-Net Lease Senior Housing Properties and Hospitals portfolios and termination fees in the Medical Office Buildings portfolio. Third quarter 2019 NOI included a $1.6 million consolidated, or $1.2 million CLNY OP share, one-time write-off of a certain tenant rent receivable in the Hospitals portfolio. Excluding these one-time items from same store NOI, the healthcare same store portfolio sequential quarter to quarter comparable NOI would have been flat. |
(2) | CLNY OP Share represents Consolidated NOI multiplied by CLNY OP's interest of 71% as of December 31, 2019. |
(3) | NOI includes $0.9 million consolidated or $0.7 million CLNY OP share of interest earned related to $43 million consolidated or $30 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended December 31, 2019. For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
(4) | Occupancy % for Senior Housing - Operating represents average of the presented quarter, MOB’s is as of last day in the quarter and for Triple-Net Lease represents average of the prior quarter. Occupancy represents real estate property operator’s patient occupancy for all types except MOB. |
(5) | Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR. |
Colony Capital | Supplemental Financial Report | 30 |
VIb. Healthcare Real Estate - Portfolio Overview |
(As of or for the three months ended December 31, 2019, unless otherwise noted) | |||||||||||||||
Triple-Net Lease Coverage(1) | % of Triple-Net Lease TTM NOI as of September 30, 2019 | ||||||||||||||
September 30, 2019 TTM Lease Coverage | # of Leases | Senior Housing | Skilled Nursing Facilities & Hospitals | % Triple-Net Lease NOI | WA Remaining Lease Term | ||||||||||
Less than 0.99x | 6 | 11 | % | 16 | % | 27 | % | 7 yrs | |||||||
1.00x - 1.09x | 3 | — | % | 9 | % | 9 | % | 7 yrs | |||||||
1.10x - 1.19x | — | — | % | — | % | — | % | — | |||||||
1.20x - 1.29x | 1 | — | % | 11 | % | 11 | % | 8 yrs | |||||||
1.30x - 1.39x | 2 | — | % | 7 | % | 7 | % | 4 yrs | |||||||
1.40x - 1.49x | 1 | 20 | % | — | % | 20 | % | 15 yrs | |||||||
1.50x and greater | 4 | 2 | % | 24 | % | 26 | % | 4 yrs | |||||||
Total / W.A. | 17 | 33 | % | 67 | % | 100 | % | 8 yrs |
Revenue Mix(2) | September 30, 2019 TTM | ||||||||
Private Pay | Medicare | Medicaid | |||||||
Senior Housing - Operating | 86 | % | 3 | % | 11 | % | |||
Medical Office Buildings | 100 | % | — | % | — | % | |||
Triple-Net Lease: | |||||||||
Senior Housing | 64 | % | — | % | 36 | % | |||
Skilled Nursing Facilities | 26 | % | 24 | % | 50 | % | |||
Hospitals | 15 | % | 40 | % | 45 | % | |||
W.A. | 59 | % | 12 | % | 29 | % |
(1) | Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR. Represents leases with EBITDAR coverage in each listed range. Excludes interest income associated with triple-net lease senior housing and hospital types. Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator. |
(2) | Revenue mix represents percentage of revenues derived from private, Medicare and Medicaid payor sources. The payor source percentages for the hospital category excludes two operating partners, who do not track or report payor source data and totals approximately one-third of NOI in the hospital category. Overall percentages are weighted by NOI exposure in each category. |
Colony Capital | Supplemental Financial Report | 31 |
VIb. Healthcare Real Estate - Portfolio Overview (cont’d) |
($ in thousands; as of or for the three months ended December 31, 2019, unless otherwise noted) | |||||||
Top 10 Geographic Locations by NOI | |||||||
Number of properties | NOI | ||||||
United Kingdom | 46 | $ | 10,326 | ||||
Indiana | 55 | 7,613 | |||||
Illinois | 35 | 6,703 | |||||
Florida | 25 | 5,941 | |||||
Oregon | 31 | 5,704 | |||||
Pennsylvania | 8 | 4,907 | |||||
Texas | 29 | 4,830 | |||||
Georgia | 21 | 4,750 | |||||
Ohio | 14 | 4,519 | |||||
California | 12 | 3,613 | |||||
Total | 276 | $ | 58,906 |
Top 10 Operators/Tenants by NOI | ||||||||||||||||
Property Type/Primary Segment | Number of properties | NOI | % Occupied | TTM Lease Coverage | WA Remaining Lease Term | |||||||||||
Senior Lifestyle | Sr. Housing / RIDEA | 60 | $ | 12,773 | 87.1 | % | N/A | N/A | ||||||||
Caring Homes (U.K.)(1) | Sr. Housing / NNN | 46 | 10,326 | 85.2 | % | 1.5x | 15 yrs | |||||||||
Sentosa | SNF / NNN | 8 | 4,907 | 84.0 | % | 1.3x | 8 yrs | |||||||||
Millers | SNF / NNN | 28 | 3,990 | 69.9 | % | 1.6x | N/A | |||||||||
Wellington Healthcare | SNF / NNN | 10 | 3,839 | 91.0 | % | 1.0x | 7 yrs | |||||||||
Frontier | Sr. Housing / RIDEA / NNN | 20 | 3,373 | 83.9 | % | N/A | N/A | |||||||||
Landmark | Hospital | 5 | 3,015 | 65.0 | % | 0.8x | 14 yrs | |||||||||
Regency | SNF / NNN | 14 | 2,909 | 75.7 | % | 0.8x | 10 yrs | |||||||||
Opis | SNF / NNN | 11 | 2,879 | 91.5 | % | 1.3x | 4 yrs | |||||||||
Consulate | SNF / NNN | 10 | 2,393 | 87.6 | % | 1.1x | 8 yrs | |||||||||
Total | 212 | $ | 50,404 |
(1) | Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator. |
Colony Capital | Supplemental Financial Report | 32 |
VIIa. Hospitality Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended December 31, 2019, unless otherwise noted) | CLNY OP share of consolidated amount(1) | |||||||
NOI before FF&E Reserve | Consolidated amount | |||||||
NOI before FF&E Reserve: | ||||||||
Select Service | $ | 28,440 | $ | 26,705 | ||||
Extended Stay | 23,554 | 22,117 | ||||||
Full Service | 2,135 | 2,005 | ||||||
Total NOI before FF&E Reserve(2) | $ | 54,129 | $ | 50,827 |
Portfolio overview by type | ||||||||||||||||||||||||
Number of hotels | Number of rooms | Avg. qtr. % occupancy | Avg. daily rate (ADR) | RevPAR | NOI before FF&E Reserve | NOI before FF&E Reserve margin | ||||||||||||||||||
Select service | 87 | 11,737 | 68.4 | % | $ | 121 | $ | 83 | $ | 28,440 | 28.2 | % | ||||||||||||
Extended stay | 66 | 7,936 | 74.6 | % | 128 | 95 | 23,554 | 32.5 | % | |||||||||||||||
Full service | 4 | 966 | 66.7 | % | 143 | 96 | 2,135 | 16.2 | % | |||||||||||||||
Total / W.A. | 157 | 20,639 | 70.7 | % | $ | 125 | $ | 88 | $ | 54,129 | 29.0 | % |
Same store financial/operating results related to the segment by brand | ||||||||||||||||||||||||||||||||||
Avg. qtr. % occupancy | Avg. daily rate (ADR) | RevPAR | NOI before FF&E Reserve | |||||||||||||||||||||||||||||||
Brand | Q4 2019 | Q4 2018 | Q4 2019 | Q4 2018 | Q4 2019 | Q4 2018 | Q4 2019(3) | Q4 2018(3) | % Change | |||||||||||||||||||||||||
Marriott | 69.4 | % | 70.6 | % | $ | 124 | $ | 127 | $ | 86 | $ | 89 | $ | 41,179 | $ | 47,347 | (13.0 | )% | ||||||||||||||||
Hilton | 75.1 | % | 75.8 | % | 125 | 127 | 94 | 96 | 9,607 | 9,546 | 0.6 | % | ||||||||||||||||||||||
Other | 77.5 | % | 77.9 | % | 128 | 134 | 100 | 105 | 2,956 | 3,118 | (5.2 | )% | ||||||||||||||||||||||
Total / W.A. | 70.8 | % | 71.9 | % | $ | 125 | $ | 127 | $ | 88 | $ | 91 | $ | 53,742 | $ | 60,011 | (10.4 | )% |
(1) | CLNY OP Share represents Consolidated NOI before FF&E Reserve multiplied by CLNY OP's interest of 94% as of December 31, 2019. |
(2) | Q4 2019 FF&E reserve was $8.1 million consolidated or $7.6 million CLNY OP share. For a reconciliation of net income/(loss) attributable to common stockholders to NOI please refer to the appendix to this presentation. |
(3) | Excluding the impact of an aggregate $1.9 million of one-time events in the fourth quarter of 2018 and room revenue displacement in the fourth quarter of 2019, fourth quarter 2019 NOI before FFE Reserve decreased (7.6)% compared to the same period last year. |
Colony Capital | Supplemental Financial Report | 33 |
VIIb. Hospitality Real Estate - Portfolio Overview |
($ in thousands; as of December 31, 2019, unless otherwise noted) | |||||||||||||||||||
Top 10 Geographic Locations by NOI before FF&E Reserve | Number of hotels | Number of rooms | Number of rooms-select service | Number of rooms-extended stay | Number of rooms-full service | NOI before FF&E Reserve | |||||||||||||
California | 18 | 2,254 | 1,243 | 1,011 | — | $ | 9,580 | ||||||||||||
Texas | 26 | 2,939 | 1,661 | 1,278 | — | 6,047 | |||||||||||||
Florida | 12 | 2,066 | 1,187 | 291 | 588 | 5,365 | |||||||||||||
New Jersey | 12 | 1,884 | 718 | 942 | 224 | 4,731 | |||||||||||||
New York | 8 | 1,010 | 710 | 300 | — | 2,713 | |||||||||||||
New Hampshire | 6 | 662 | 339 | 323 | — | 2,542 | |||||||||||||
Virginia | 9 | 1,183 | 920 | 263 | — | 2,526 | |||||||||||||
North Carolina | 7 | 981 | 831 | 150 | — | 2,407 | |||||||||||||
Michigan | 6 | 809 | 601 | 208 | — | 2,293 | |||||||||||||
Washington | 5 | 664 | 160 | 504 | — | 2,005 | |||||||||||||
Total / W.A. | 109 | 14,452 | 8,370 | 5,270 | 812 | $ | 40,209 |
Colony Capital | Supplemental Financial Report | 34 |
VIIIa. CLNC |
($ in thousands, except as noted and per share data; as of December 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
Colony Credit Real Estate, Inc. (NYSE: CLNC) | ||||||||
CLNY OP interest in CLNC as of February 25, 2020 | 36.4 | % | 36.4 | % | ||||
CLNC shares beneficially owned by OP and common stockholders | 48.0 million | 48.0 million | ||||||
CLNC share price as of February 25, 2020 | $ | 13.05 | $ | 13.05 | ||||
Total market value of CLNC shares | $ | 625,565 | $ | 625,565 | ||||
Net carrying value - CLNC | $ | 725,443 | $ | 725,443 | ||||
Colony Capital | Supplemental Financial Report | 35 |
IX. Other Equity and Debt Summary |
($ in thousands; as of December 31, 2019) | Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Assets | Equity | Assets | Equity | ||||||||||||
Strategic(1) | |||||||||||||||
Digital - Direct Investments and Digital Colony Partners GP Co-investments | 1,493,909 | 954,754 | 342,879 | 232,891 | |||||||||||
GP Co-investments in CDCF IV and CDCF V Investments | 2,129,602 | 1,617,815 | 408,520 | 280,848 | |||||||||||
Other GP Co-investments | 710,675 | 365,664 | 701,040 | 356,029 | |||||||||||
Strategic Subtotal | 4,334,186 | 2,938,233 | 1,452,439 | 869,768 | |||||||||||
Non-Strategic(1) | |||||||||||||||
Other real estate equity | 2,181,379 | 943,982 | 1,165,315 | 551,016 | |||||||||||
Net lease real estate equity | 188,060 | 83,999 | 187,015 | 83,574 | |||||||||||
Real estate debt | 357,015 | 357,015 | 246,503 | 246,503 | |||||||||||
CRE securities and real estate PE fund investments | 60,251 | 60,251 | 60,251 | 60,251 | |||||||||||
Non-Strategic Subtotal | 2,786,705 | 1,445,247 | 1,659,084 | 941,344 | |||||||||||
Other Equity and Debt Total | $ | 7,120,891 | $ | 4,383,480 | $ | 3,111,523 | $ | 1,811,112 |
(1) | For consolidated real estate equity assets, amounts include all components related to real estate assets, including tangible real estate and lease-related intangibles, and excludes accumulated depreciation, and for all other assets, amounts represent carrying value of investments. |
Colony Capital | Supplemental Financial Report | 36 |
IXa. Other Equity and Debt - Strategic Investments |
($ in thousands, except as noted and per share data; as of December 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
Digital - Direct Investments and Digital Colony Partners GP Co-investments(1) | ||||||||
Assets - carrying value | $ | 1,493,909 | $ | 342,879 | ||||
Debt - UPB | 539,155 | 109,988 | ||||||
Net carrying value | $ | 954,754 | $ | 232,891 | ||||
CLNY's GP Co-investments in CDCF IV and CDCF V Investments | ||||||||
Assets - carrying value(2) | $ | 2,129,602 | $ | 408,520 | ||||
Debt - UPB | 511,787 | 127,672 | ||||||
Net carrying value | $ | 1,617,815 | $ | 280,848 | ||||
NBV by Geography: | ||||||||
U.S. | 28.5 | % | 19.7 | % | ||||
Europe | 71.5 | % | 80.3 | % | ||||
Total | 100.0 | % | 100.0 | % | ||||
Other GP Co-investments(3) | ||||||||
Assets - carrying value(4)(5) | $ | 710,675 | $ | 701,040 | ||||
Debt - UPB(5) | 345,011 | 345,011 | ||||||
Net carrying value | $ | 365,664 | $ | 356,029 |
(1) | In December 2019, the Company made its inaugural direct balance sheet investment in digital real estate by acquiring a 20.4% interest in DataBank. |
(2) | $821 million consolidated or $127 million CLNY OP share of assets are classified as Loans Receivable on the Company's balance sheet. |
(3) | Other GP co-investments represents: i) seed investments in certain registered investment companies sponsored by the Company, ii) investments in the general partnership of third party real estate operators primarily to seed investment commitments with their limited partners for which the Company will receive its share of earnings and incentive fees, or iii) general partnership capital in a fund or investment. |
(4) | $358 million consolidated and CLNY OP share of assets are classified as Loans Receivable on the Company's balance sheet. |
(5) | Debt includes $117 million of derivative liability with a corresponding derivative asset in Other GP Co-investments Assets above. |
Colony Capital | Supplemental Financial Report | 37 |
IXb. Other Equity and Debt - Net Lease and Other Real Estate Equity |
($ in thousands; as of December 31, 2019, unless otherwise noted) | ||||||||||||||||||||
Net Lease Real Estate Equity | Number of buildings | Rentable square feet (thousands) | Consolidated amount | CLNY OP share of consolidated amount | % leased at end of period | Weighted average remaining lease term | ||||||||||||||
NOI | NOI | |||||||||||||||||||
U.S. office | 3 | 674 | $ | 771 | $ | 770 | 85.7 | % | 4.9 | |||||||||||
Total / W.A. | 3 | 674 | $ | 771 | $ | 770 | 85.7 | % | 4.9 |
Other Real Estate Equity | Number of buildings | Rentable square feet (thousands) | Consolidated amount | CLNY OP share of consolidated amount | % leased at end of period | Weighted average remaining lease term | ||||||||||||||
Undepreciated carrying value | Undepreciated carrying value | |||||||||||||||||||
U.S.: | ||||||||||||||||||||
Office | 2 | 230 | $ | 40,378 | $ | 40,170 | 81.2 | % | 2.8 | |||||||||||
Hotel(1) | 89 | N/A | 1,224,899 | 675,164 | 66.5 | % | N/A | |||||||||||||
Europe: | ||||||||||||||||||||
Office | 14 | 472 | 70,551 | 35,276 | 74.9 | % | 14.6 | |||||||||||||
Mixed / Retail | 104 | 3,205 | 528,541 | 177,295 | 50.4 | % | 4.8 | |||||||||||||
Total / W.A. | 209 | 3,907 | $ | 1,864,369 | $ | 927,905 | 55.2 | % | 5.9 | |||||||||||
Unconsolidated joint ventures (Other RE Equity) | ||||||||||||||||||||
Preferred equity: | ||||||||||||||||||||
Multifamily | $ | 128,285 | $ | 128,285 | ||||||||||||||||
Equity & Other: | ||||||||||||||||||||
Albertsons | 89,129 | 44,565 | ||||||||||||||||||
Residential Land | 70,854 | 35,818 | ||||||||||||||||||
Other | 28,742 | 28,742 | ||||||||||||||||||
Total | $ | 317,010 | $ | 237,410 | ||||||||||||||||
(1) | Includes $24 million consolidated or $13 million CLNY OP share of restricted cash. |
Colony Capital | Supplemental Financial Report | 38 |
IXc. Other Equity and Debt - Real Estate Debt |
($ in thousands, except as noted; as of December 31, 2019, unless otherwise noted) | ||||||||
Portfolio Overview(1)(2) | ||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||
Non-PCI loans | ||||||||
Carrying value - consolidated | $ | 300,825 | $ | 214,573 | ||||
Carrying value - equity method investments | 11,160 | 6,089 | ||||||
. | ||||||||
Other | ||||||||
Carrying value - real estate assets (REO) | 45,030 | 25,841 | ||||||
Total Portfolio | ||||||||
Carrying value - consolidated | 300,825 | 214,573 | ||||||
Carrying value - equity method investments | 11,160 | 6,089 | ||||||
Carrying value - real estate assets (REO) | 45,030 | 25,841 | ||||||
Non-recourse investment-level financing (UPB) | — | — |
(1) | Excludes $43 million consolidated or $30 million CLNY OP share carrying value of healthcare real estate development loans. These loans are included in the Company's healthcare real estate segment. |
(2) | Strategic loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 39 |
IXc. Other Equity and Debt - Real Estate Debt (cont’d) |
($ in thousands; as of or for the three months ended December 31, 2019, unless otherwise noted) | ||||||||||||||
Non-strategic real estate debt by loan type(1)(2) | ||||||||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Net carrying amount | Net carrying amount | Weighted average yield | Weighted average maturity in years | |||||||||||
Non-PCI loans | ||||||||||||||
Fixed rate | ||||||||||||||
First mortgage loans | $ | 33,988 | $ | 16,994 | — | % | 0.4 | |||||||
Second mortgage loans / B-notes | 181,172 | 101,387 | 9.3 | % | 1.5 | |||||||||
Mezzanine loans | 64,134 | 61,387 | — | % | 1.6 | |||||||||
Corporate | 27,287 | 27,287 | 8.2 | % | 7.0 | |||||||||
Total fixed rate non-PCI loans | 306,581 | 207,055 | 5.6 | % | 2.1 | |||||||||
Variable rate | ||||||||||||||
First mortgage loans | 42,394 | 42,394 | 8.2 | % | 0.9 | |||||||||
Total variable rate non-PCI loans | 42,394 | 42,394 | 8.9 | % | 1.2 | |||||||||
Total non-PCI loans | 348,975 | 249,449 | ||||||||||||
Allowance for loan losses | (48,150 | ) | (34,876 | ) | ||||||||||
Total non-PCI loans, net of allowance for loan losses | 300,825 | 214,573 | ||||||||||||
Total loans receivable, net of allowance for loan losses | $ | 300,825 | $ | 214,573 |
(1) | Excludes $43 million consolidated or $30 million CLNY OP share carrying value of healthcare real estate development loans. These loans are included in the Company's healthcare real estate segment. |
(2) | Strategic loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 40 |
IXc. Other Equity and Debt - Real Estate Debt (cont’d) |
($ in thousands; as of or for the three months ended December 31, 2019, unless otherwise noted) | ||||||||||||||
Non-strategic real estate debt by collateral type(1)(2) | ||||||||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Net carrying amount | Net carrying amount | Weighted average yield | Weighted average maturity in years | |||||||||||
Non-PCI Loans | ||||||||||||||
Retail | $ | 106,528 | $ | 103,781 | 3.4 | % | 1.3 | |||||||
Office | 143,406 | 71,703 | 13.1 | % | 2.1 | |||||||||
Land | 23,604 | 11,802 | — | % | 0.4 | |||||||||
Corporate | 27,287 | 27,287 | 8.2 | % | 7.0 | |||||||||
Total non-PCI loans, net of allowance for loan losses | 300,825 | 214,573 | 7.1 | % | 2.2 | |||||||||
Total loans receivable, net of allowance for loan losses | $ | 300,825 | $ | 214,573 |
(1) | Excludes $43 million consolidated or $30 million CLNY OP share carrying value of healthcare real estate development loans. These loans are included in the Company's healthcare real estate segment. |
(2) | Strategic loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 41 |
IXd. Other Equity and Debt - CRE Securities and Real Estate PE Fund Interests |
($ in thousands; as of December 31, 2019) | |||||
Portfolio Overview | Carrying Value | ||||
Deconsolidated CDO bonds | $ | 54,860 | |||
Real estate PE fund interests | 5,391 | ||||
Colony Capital | Supplemental Financial Report | 42 |
Colony Capital | Supplemental Financial Report | 43 |
Xa. Appendices - Definitions |
Colony Capital | Supplemental Financial Report | 44 |
Xa. Appendices - Definitions |
Colony Capital | Supplemental Financial Report | 45 |
Xb. Appendices - Reconciliation of Net Income (Loss) to NOI |
($ in thousands; for the three months ended December 31, 2019) | ||||||||||||||||
NOI Determined as Follows | Healthcare | Industrial | Hospitality | Other Equity and Debt—Net Lease Properties | ||||||||||||
Total revenues | $ | 154,378 | $ | 77,611 | $ | 186,450 | $ | 2,854 | ||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (11,370 | ) | (3,196 | ) | 313 | (885 | ) | |||||||||
Interest income | (31 | ) | (486 | ) | 6 | — | ||||||||||
Other income | (300 | ) | — | 70 | — | |||||||||||
Property operating expenses(1) | (66,106 | ) | (19,382 | ) | (132,710 | ) | (1,198 | ) | ||||||||
Compensation and administrative expense(1) | — | (1,386 | ) | — | — | |||||||||||
NOI(2) | $ | 76,571 | $ | 53,161 | $ | 54,129 | $ | 771 | ||||||||
Reconciliation of Net Income (Loss) from Continuing Operations to NOI | ||||||||||||||||
Healthcare | Industrial | Hospitality | ||||||||||||||
Income (loss) | $ | (38,608 | ) | $ | 1,426,219 | $ | (43,119 | ) | ||||||||
Adjustments: | ||||||||||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (11,370 | ) | (3,196 | ) | 313 | |||||||||||
Interest income | (31 | ) | (486 | ) | 6 | |||||||||||
Interest expense | 41,930 | 36,381 | 45,484 | |||||||||||||
Transaction, investment and servicing costs | 3,137 | 66 | 1,787 | |||||||||||||
Depreciation and amortization | 41,208 | 9,323 | 36,035 | |||||||||||||
Impairment loss | 43,132 | — | 14,649 | |||||||||||||
Compensation and administrative expense | 2,482 | 20,265 | 2,096 | |||||||||||||
Gain on sale of real estate | (551 | ) | (1,429,822 | ) | — | |||||||||||
Other (gain) loss, net | (5,690 | ) | (1,407 | ) | (1,492 | ) | ||||||||||
Other income | (300 | ) | — | 70 | ||||||||||||
Income tax (benefit) expense | 1,232 | (4,182 | ) | (1,700 | ) | |||||||||||
NOI(2) | $ | 76,571 | $ | 53,161 | $ | 54,129 |
(1) | For healthcare and hospitality, property operating expenses includes property management fees paid to third parties. For industrial, there are direct costs of managing the portfolio which are included in compensation expense. |
(2) | For hospitality, NOI is before FF&E Reserve. |
Colony Capital | Supplemental Financial Report | 46 |
Xb. Appendices - Reconciliation of Net Income (Loss) to NOI (cont’d) |
($ in thousands; for the three months ended December 31, 2019) | ||||
Reconciliation of Net Income from Continuing Operations of Other Equity and Debt Segment to NOI of Net Lease Real Estate Equity | ||||
Other Equity and Debt | ||||
Income from continuing operations | $ | 27,185 | ||
Adjustments: | ||||
Property operating income of other real estate equity | (104,191 | ) | ||
Straight-line rent revenue and amortization of above- and below-market lease intangibles for net lease real estate equity | (885 | ) | ||
Interest income | (43,324 | ) | ||
Fee and other income | (4,329 | ) | ||
Property operating expense of other real estate equity | 66,561 | |||
Interest expense | 26,537 | |||
Transaction, investment and servicing costs | 20,333 | |||
Depreciation and amortization | 22,612 | |||
Provision for loan loss | 33 | |||
Impairment loss | 2,492 | |||
Compensation and administrative expense | 11,787 | |||
Gain on sale of real estate assets | (18,611 | ) | ||
Other loss, net | 16,489 | |||
Earnings of investments in unconsolidated ventures | (25,613 | ) | ||
Income tax expense | 3,695 | |||
NOI of net lease real estate equity | $ | 771 |
Colony Capital | Supplemental Financial Report | 47 |
Xc. Appendices - Industrial Real Estate Segment Discontinued Operations |
($ in thousands) (unaudited) | Three Months Ended December 31, 2019 | |||
Revenues | ||||
Property operating income | $ | 76,270 | ||
Interest income | 486 | |||
Other income | 855 | |||
Total revenues | 77,611 | |||
Expenses | ||||
Property operating expense | 19,382 | |||
Interest expense | 36,381 | |||
Investment and servicing expense | 64 | |||
Transaction costs | 2 | |||
Depreciation and amortization | 9,323 | |||
Compensation expense | ||||
Cash and equity-based compensation | 19,538 | |||
Administrative expenses | 2,113 | |||
Total expenses | 86,803 | |||
Other income (loss) | ||||
Gain on sale of real estate assets | 1,429,822 | |||
Other gain (loss), net | 1,407 | |||
Income (loss) before income taxes | 1,422,037 | |||
Income tax benefit (expense) | 4,182 | |||
Net income (loss) | 1,426,219 | |||
Net income (loss) attributable to noncontrolling interests: | ||||
Investment entities | 943,647 | |||
Operating Company | 47,078 | |||
Net income (loss) attributable to Colony Capital, Inc. | 435,494 | |||
Net income (loss) attributable to common stockholders | $ | 435,494 |
Colony Capital | Supplemental Financial Report | 48 |